{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"103","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"C","per_page":12,"people":[{"id":445975,"version":1,"owner_type":"Person","owner_id":3930,"payload":{"bio":"\u003cp\u003eAlexander Calfo has repeatedly won the most difficult and challenging\u0026nbsp;trials involving medical devices and pharmaceuticals, airplane crashes, automotive products liability, class actions, toxic tort, insurance coverage, and commercial business disputes. \u0026nbsp;He has been awarded five of the Top 10 winning first-chair trial verdicts in California by \u003cem\u003eThe Daily Journal\u003c/em\u003e.\u0026nbsp; His verdicts have also been selected Top 5 nationally by LexisNexis, and Courtroom View Network recently named another high-profile national verdict as the \u0026ldquo;Number One Impressive Defense Victory in the United States.\u0026rdquo; \u0026nbsp;\u003cem\u003eThe Los Angeles Business Journal\u003c/em\u003e\u0026nbsp;chose Alex as a 2022 Top 100 Lawyer for his legal skill, achievements, and exemplary leadership.\u0026nbsp; The award also recognized him as one of the first partners to join King \u0026amp; Spalding\u0026rsquo;s Los Angeles office and \u0026ldquo;has been instrumental in building the firm\u0026rsquo;s reputation as a west coast trial powerhouse.\u0026rdquo;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlex is inducted in the prestigious American College of Trial Lawyers, the premier trial association in North America whose members are elected to the College for demonstrating the highest standards of trial advocacy, ethical conduct, professionalism, and collegiality.\u0026nbsp;He is also a member of the American Board of Trial Advocates (ABOTA), an invitation-only group of attorneys who have the required combination of skills, integrity, and trial experience.\u003c/p\u003e\n\u003cp\u003eCourtroom View Network has awarded Alex its Number One all-time \u0026ldquo;must watch\u0026rdquo; defense verdict for the entire state of California. \u0026nbsp;Alex was also named \u0026ldquo;Lawyer of the Year\u0026rdquo; in the \u003cem\u003eLos Angeles Business Journal\u003c/em\u003e\u0026nbsp;for exceptional legal skill and achievement. \u0026nbsp;\u003cem\u003eBenchmark Litigation\u003c/em\u003e\u0026nbsp;recognizes him as a California Litigation Star and a Tier One National Product Liability Star. \u0026nbsp;\u003cem\u003eLegal 500 U.S.\u003c/em\u003e\u0026nbsp;ranks Alex \u0026ldquo;Among the Best in Product Liability, Mass Tort and Class Actions in Pharmaceutical and Medical Device Litigation.\u0026rdquo;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHe is a recipient of The Best Lawyers in America award and, in 2024, was selected by the National Trial Lawyers as a Top 100 Trial Lawyer.\u0026nbsp;He was honored as a \"Top 25 Mass Tort and Product Liability lawyer in the United States\" by the National Trial Lawyers in 2026. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlex is proudly named to the Board of Trustees of Creighton University - his Law School Alma Mater.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlex serves as a frequent author, speaker and presenter on a variety of trial and litigation topics.\u003c/p\u003e","slug":"alexander-calfo","email":"acalfo@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":1,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":5,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":6,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":7,"source":"smartTags"},{"id":764,"guid":"764.smart_tags","index":8,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":9,"source":"capabilities"},{"id":1256,"guid":"1256.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Calfo","nick_name":"Alexander","clerkships":[],"first_name":"Alexander","title_rank":9999,"updated_by":202,"law_schools":[{"id":518,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1991-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAlexander Calfo has repeatedly won the most difficult and challenging\u0026nbsp;trials involving medical devices and pharmaceuticals, airplane crashes, automotive products liability, class actions, toxic tort, insurance coverage, and commercial business disputes. \u0026nbsp;He has been awarded five of the Top 10 winning first-chair trial verdicts in California by \u003cem\u003eThe Daily Journal\u003c/em\u003e.\u0026nbsp; His verdicts have also been selected Top 5 nationally by LexisNexis, and Courtroom View Network recently named another high-profile national verdict as the \u0026ldquo;Number One Impressive Defense Victory in the United States.\u0026rdquo; \u0026nbsp;\u003cem\u003eThe Los Angeles Business Journal\u003c/em\u003e\u0026nbsp;chose Alex as a 2022 Top 100 Lawyer for his legal skill, achievements, and exemplary leadership.\u0026nbsp; The award also recognized him as one of the first partners to join King \u0026amp; Spalding\u0026rsquo;s Los Angeles office and \u0026ldquo;has been instrumental in building the firm\u0026rsquo;s reputation as a west coast trial powerhouse.\u0026rdquo;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlex is inducted in the prestigious American College of Trial Lawyers, the premier trial association in North America whose members are elected to the College for demonstrating the highest standards of trial advocacy, ethical conduct, professionalism, and collegiality.\u0026nbsp;He is also a member of the American Board of Trial Advocates (ABOTA), an invitation-only group of attorneys who have the required combination of skills, integrity, and trial experience.\u003c/p\u003e\n\u003cp\u003eCourtroom View Network has awarded Alex its Number One all-time \u0026ldquo;must watch\u0026rdquo; defense verdict for the entire state of California. \u0026nbsp;Alex was also named \u0026ldquo;Lawyer of the Year\u0026rdquo; in the \u003cem\u003eLos Angeles Business Journal\u003c/em\u003e\u0026nbsp;for exceptional legal skill and achievement. \u0026nbsp;\u003cem\u003eBenchmark Litigation\u003c/em\u003e\u0026nbsp;recognizes him as a California Litigation Star and a Tier One National Product Liability Star. \u0026nbsp;\u003cem\u003eLegal 500 U.S.\u003c/em\u003e\u0026nbsp;ranks Alex \u0026ldquo;Among the Best in Product Liability, Mass Tort and Class Actions in Pharmaceutical and Medical Device Litigation.\u0026rdquo;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eHe is a recipient of The Best Lawyers in America award and, in 2024, was selected by the National Trial Lawyers as a Top 100 Trial Lawyer.\u0026nbsp;He was honored as a \"Top 25 Mass Tort and Product Liability lawyer in the United States\" by the National Trial Lawyers in 2026. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAlex is proudly named to the Board of Trustees of Creighton University - his Law School Alma Mater.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAlex serves as a frequent author, speaker and presenter on a variety of trial and litigation topics.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5155},{"id":5155},{"id":5155}]},"capability_group_id":3},"created_at":"2026-02-19T14:43:48.000Z","updated_at":"2026-02-19T14:43:48.000Z","searchable_text":"Calfo{{ FIELD }}Alexander Calfo has repeatedly won the most difficult and challenging trials involving medical devices and pharmaceuticals, airplane crashes, automotive products liability, class actions, toxic tort, insurance coverage, and commercial business disputes.  He has been awarded five of the Top 10 winning first-chair trial verdicts in California by The Daily Journal.  His verdicts have also been selected Top 5 nationally by LexisNexis, and Courtroom View Network recently named another high-profile national verdict as the “Number One Impressive Defense Victory in the United States.”  The Los Angeles Business Journal chose Alex as a 2022 Top 100 Lawyer for his legal skill, achievements, and exemplary leadership.  The award also recognized him as one of the first partners to join King \u0026amp; Spalding’s Los Angeles office and “has been instrumental in building the firm’s reputation as a west coast trial powerhouse.” \nAlex is inducted in the prestigious American College of Trial Lawyers, the premier trial association in North America whose members are elected to the College for demonstrating the highest standards of trial advocacy, ethical conduct, professionalism, and collegiality. He is also a member of the American Board of Trial Advocates (ABOTA), an invitation-only group of attorneys who have the required combination of skills, integrity, and trial experience.\nCourtroom View Network has awarded Alex its Number One all-time “must watch” defense verdict for the entire state of California.  Alex was also named “Lawyer of the Year” in the Los Angeles Business Journal for exceptional legal skill and achievement.  Benchmark Litigation recognizes him as a California Litigation Star and a Tier One National Product Liability Star.  Legal 500 U.S. ranks Alex “Among the Best in Product Liability, Mass Tort and Class Actions in Pharmaceutical and Medical Device Litigation.” \nHe is a recipient of The Best Lawyers in America award and, in 2024, was selected by the National Trial Lawyers as a Top 100 Trial Lawyer. He was honored as a \"Top 25 Mass Tort and Product Liability lawyer in the United States\" by the National Trial Lawyers in 2026.  \nAlex is proudly named to the Board of Trustees of Creighton University - his Law School Alma Mater. \nAlex serves as a frequent author, speaker and presenter on a variety of trial and litigation topics. Partner Marquette University Marquette University Law School Creighton University Creighton University School of Law U.S. District Court for the Central District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California U.S. District Court for the District of Colorado California American Bar Association Defense Research Institute American Board of Trial Advocates Los Angeles County Bar Association Center for International Studies","searchable_name":"Alexander Calfo","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":443962,"version":1,"owner_type":"Person","owner_id":6804,"payload":{"bio":"\u003cp\u003eAndrew J. Calica is a partner in our New York office and a member of King \u0026amp; Spalding\u0026rsquo;s Product Liability and Mass Torts practice group. He represents chemical and pharmaceutical companies in toxic tort, product liability and mass and class actions. Andrew also has substantial multi-district litigation experience representing financial institutions in antitrust and commodities litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAndrew also advises clients in complex commercial disputes and on resolution strategies. Andrew\u0026rsquo;s recent engagements include representing global chemical companies in water contamination cases.\u003c/p\u003e\n\u003cp\u003eHe is a co-author of several chapters in the \u003cem\u003eElectronic Discovery Deskbook\u003c/em\u003e, a treatise on electronic discovery and records management published by the Practicing Law Institute.\u003c/p\u003e","slug":"andrew-calica","email":"acalica@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented a global chemical company in PFAS personal injury, medical monitoring, property damage, water district, customer class, and natural resource damages cases.\u003c/p\u003e","\u003cp\u003eSecured trial victory for global bank on claim of breach of the implied covenant of good faith and fair dealing in connection with a revolving credit agreement.\u003c/p\u003e","\u003cp\u003eObtained dismissal of Commodity Exchange Act claims against global bank in LIBOR class action.\u003c/p\u003e","\u003cp\u003eRepresented global pharmaceutical company in connection with N.Y. False Claims Act claim by New York Attorney General.\u003c/p\u003e","\u003cp\u003eRepresented brand name pharmaceutical companies as national counsel supervising cases involving 8,000 product liability plaintiffs.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eBell v. Pfizer (8th Cir. 2013); Fullington v. Pfizer (8th Cir. 2013); Strayhorn v. Wyeth (6th Cir. 2013); Eckhardt v. Qualitest (5th Cir. 2014); Huck v. Trimark (Iowa 2014); Smith v. Wyeth (6th Cir. 2011); Mensing v. Wyeth (8th Cir. 2009).\u003c/em\u003e Obtained dismissal for brand name pharmaceutical company in failure to warn cases involving ingestion of generic pharmaceuticals.\u003c/p\u003e","\u003cp\u003eAssisted a multi-national pharmaceutical company in a licensing dispute before the ICC International Court of Arbitration.\u003c/p\u003e","\u003cp\u003eRepresented an owner participant in a contested bankruptcy proceeding concerning tax indemnity claims arising out of the purchase of aircraft.\u003c/p\u003e","\u003cp\u003eRepresented a global pharmaceutical company in connection with an internal investigation arising out of a clinical trial.\u003c/p\u003e","\u003cp\u003eDefended a leading broker dealer against $500 million claims that it colluded to inflate the valuation of mortgage-backed securities held by a hedge fund customer.\u003c/p\u003e","\u003cp\u003eDefended a global bank in a commercial arbitration that involved an accounting dispute with the bank\u0026rsquo;s former subsidiary.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":17,"guid":"17.capabilities","index":0,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":1,"source":"capabilities"},{"id":14,"guid":"14.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":699,"guid":"699.smart_tags","index":5,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":6,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":7,"source":"smartTags"},{"id":1206,"guid":"1206.smart_tags","index":8,"source":"smartTags"}],"is_active":true,"last_name":"Calica","nick_name":"Andrew","clerkships":[],"first_name":"Andrew","title_rank":9999,"updated_by":202,"law_schools":[{"id":512,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2004-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Product Liability Rising Star ","detail":"Law360"},{"title":"New York Metro Super Lawyers Rising Star","detail":"SuperLawyers"}],"linked_in_url":"https://www.linkedin.com/in/andrew-calica-40607467/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAndrew J. Calica is a partner in our New York office and a member of King \u0026amp; Spalding\u0026rsquo;s Product Liability and Mass Torts practice group. He represents chemical and pharmaceutical companies in toxic tort, product liability and mass and class actions. Andrew also has substantial multi-district litigation experience representing financial institutions in antitrust and commodities litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAndrew also advises clients in complex commercial disputes and on resolution strategies. Andrew\u0026rsquo;s recent engagements include representing global chemical companies in water contamination cases.\u003c/p\u003e\n\u003cp\u003eHe is a co-author of several chapters in the \u003cem\u003eElectronic Discovery Deskbook\u003c/em\u003e, a treatise on electronic discovery and records management published by the Practicing Law Institute.\u003c/p\u003e","matters":["\u003cp\u003eRepresented a global chemical company in PFAS personal injury, medical monitoring, property damage, water district, customer class, and natural resource damages cases.\u003c/p\u003e","\u003cp\u003eSecured trial victory for global bank on claim of breach of the implied covenant of good faith and fair dealing in connection with a revolving credit agreement.\u003c/p\u003e","\u003cp\u003eObtained dismissal of Commodity Exchange Act claims against global bank in LIBOR class action.\u003c/p\u003e","\u003cp\u003eRepresented global pharmaceutical company in connection with N.Y. False Claims Act claim by New York Attorney General.\u003c/p\u003e","\u003cp\u003eRepresented brand name pharmaceutical companies as national counsel supervising cases involving 8,000 product liability plaintiffs.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eBell v. Pfizer (8th Cir. 2013); Fullington v. Pfizer (8th Cir. 2013); Strayhorn v. Wyeth (6th Cir. 2013); Eckhardt v. Qualitest (5th Cir. 2014); Huck v. Trimark (Iowa 2014); Smith v. Wyeth (6th Cir. 2011); Mensing v. Wyeth (8th Cir. 2009).\u003c/em\u003e Obtained dismissal for brand name pharmaceutical company in failure to warn cases involving ingestion of generic pharmaceuticals.\u003c/p\u003e","\u003cp\u003eAssisted a multi-national pharmaceutical company in a licensing dispute before the ICC International Court of Arbitration.\u003c/p\u003e","\u003cp\u003eRepresented an owner participant in a contested bankruptcy proceeding concerning tax indemnity claims arising out of the purchase of aircraft.\u003c/p\u003e","\u003cp\u003eRepresented a global pharmaceutical company in connection with an internal investigation arising out of a clinical trial.\u003c/p\u003e","\u003cp\u003eDefended a leading broker dealer against $500 million claims that it colluded to inflate the valuation of mortgage-backed securities held by a hedge fund customer.\u003c/p\u003e","\u003cp\u003eDefended a global bank in a commercial arbitration that involved an accounting dispute with the bank\u0026rsquo;s former subsidiary.\u003c/p\u003e"],"recognitions":[{"title":"Product Liability Rising Star ","detail":"Law360"},{"title":"New York Metro Super Lawyers Rising Star","detail":"SuperLawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11993}]},"capability_group_id":3},"created_at":"2025-12-05T05:02:01.000Z","updated_at":"2025-12-05T05:02:01.000Z","searchable_text":"Calica{{ FIELD }}{:title=\u0026gt;\"Product Liability Rising Star \", :detail=\u0026gt;\"Law360\"}{{ FIELD }}{:title=\u0026gt;\"New York Metro Super Lawyers Rising Star\", :detail=\u0026gt;\"SuperLawyers\"}{{ FIELD }}Represented a global chemical company in PFAS personal injury, medical monitoring, property damage, water district, customer class, and natural resource damages cases.{{ FIELD }}Secured trial victory for global bank on claim of breach of the implied covenant of good faith and fair dealing in connection with a revolving credit agreement.{{ FIELD }}Obtained dismissal of Commodity Exchange Act claims against global bank in LIBOR class action.{{ FIELD }}Represented global pharmaceutical company in connection with N.Y. False Claims Act claim by New York Attorney General.{{ FIELD }}Represented brand name pharmaceutical companies as national counsel supervising cases involving 8,000 product liability plaintiffs.{{ FIELD }}Bell v. Pfizer (8th Cir. 2013); Fullington v. Pfizer (8th Cir. 2013); Strayhorn v. Wyeth (6th Cir. 2013); Eckhardt v. Qualitest (5th Cir. 2014); Huck v. Trimark (Iowa 2014); Smith v. Wyeth (6th Cir. 2011); Mensing v. Wyeth (8th Cir. 2009). Obtained dismissal for brand name pharmaceutical company in failure to warn cases involving ingestion of generic pharmaceuticals.{{ FIELD }}Assisted a multi-national pharmaceutical company in a licensing dispute before the ICC International Court of Arbitration.{{ FIELD }}Represented an owner participant in a contested bankruptcy proceeding concerning tax indemnity claims arising out of the purchase of aircraft.{{ FIELD }}Represented a global pharmaceutical company in connection with an internal investigation arising out of a clinical trial.{{ FIELD }}Defended a leading broker dealer against $500 million claims that it colluded to inflate the valuation of mortgage-backed securities held by a hedge fund customer.{{ FIELD }}Defended a global bank in a commercial arbitration that involved an accounting dispute with the bank’s former subsidiary.{{ FIELD }}Andrew J. Calica is a partner in our New York office and a member of King \u0026amp; Spalding’s Product Liability and Mass Torts practice group. He represents chemical and pharmaceutical companies in toxic tort, product liability and mass and class actions. Andrew also has substantial multi-district litigation experience representing financial institutions in antitrust and commodities litigation.\nAndrew also advises clients in complex commercial disputes and on resolution strategies. Andrew’s recent engagements include representing global chemical companies in water contamination cases.\nHe is a co-author of several chapters in the Electronic Discovery Deskbook, a treatise on electronic discovery and records management published by the Practicing Law Institute. Partner Product Liability Rising Star  Law360 New York Metro Super Lawyers Rising Star SuperLawyers Wesleyan University  Cornell University Cornell Law School U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of New York U.S. District Court for the Eastern District of Michigan New York Chair Wesleyan University Annual Fund (fmr) Vice-Chair Wesleyan University Alumni Association (fmr) Chair, Wesleyan University Alumni Elected Trustee Nominating Committee (fmr) Represented a global chemical company in PFAS personal injury, medical monitoring, property damage, water district, customer class, and natural resource damages cases. Secured trial victory for global bank on claim of breach of the implied covenant of good faith and fair dealing in connection with a revolving credit agreement. Obtained dismissal of Commodity Exchange Act claims against global bank in LIBOR class action. Represented global pharmaceutical company in connection with N.Y. False Claims Act claim by New York Attorney General. Represented brand name pharmaceutical companies as national counsel supervising cases involving 8,000 product liability plaintiffs. Bell v. Pfizer (8th Cir. 2013); Fullington v. Pfizer (8th Cir. 2013); Strayhorn v. Wyeth (6th Cir. 2013); Eckhardt v. Qualitest (5th Cir. 2014); Huck v. Trimark (Iowa 2014); Smith v. Wyeth (6th Cir. 2011); Mensing v. Wyeth (8th Cir. 2009). Obtained dismissal for brand name pharmaceutical company in failure to warn cases involving ingestion of generic pharmaceuticals. Assisted a multi-national pharmaceutical company in a licensing dispute before the ICC International Court of Arbitration. Represented an owner participant in a contested bankruptcy proceeding concerning tax indemnity claims arising out of the purchase of aircraft. Represented a global pharmaceutical company in connection with an internal investigation arising out of a clinical trial. Defended a leading broker dealer against $500 million claims that it colluded to inflate the valuation of mortgage-backed securities held by a hedge fund customer. Defended a global bank in a commercial arbitration that involved an accounting dispute with the bank’s former subsidiary.","searchable_name":"Andrew Calica","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442808,"version":1,"owner_type":"Person","owner_id":5734,"payload":{"bio":"\u003cp\u003eEva Canaan\u0026rsquo;s practice focuses on the strategic development and coordination of the scientific defense in pharmaceutical and medical device products liability litigation. In addition to her law degree, Eva holds a Masters in Epidemiology from Columbia University.\u0026nbsp; Eva is adept at challenging expert witness testimony in depositions and\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;briefs in federal and state courts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eEva focuses on making complex scientific concepts accessible to judges and juries.\u0026nbsp; She routinely works with experts in a variety of scientific disciplines, including epidemiology, toxicology, teratology, and clinical medicine.\u0026nbsp; Going beyond bottom-line conclusions, Eva aggressively interrogates the data and methodology of studies and reports, often exposing flaws and weaknesses glossed over by the authors and plaintiffs\u0026rsquo; experts.\u0026nbsp; She has deposed plaintiffs\u0026rsquo; main causation experts and drafted\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eFrye\u003c/em\u003e\u0026nbsp;briefs in high-stakes litigations affecting hundreds of cases.\u0026nbsp; Eva follows the epidemiological literature related to her clients\u0026rsquo; products \u0026ndash; both in and outside of the litigation context -- and provides real-time analyses and risk-assessments to her clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"eva-canaan","email":"ecanaan@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting major pharmaceutical company in federal multidistrict and state court litigation relating to allegations of cancer from a heartburn medication. Leading all science and expert work, encompassing epidemiology, toxicology, oncology, gastroenterology, pharmacology and analytical chemistry. Successfully deposed, briefed, and argued\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;motion relating to Plaintiffs\u0026rsquo; main epidemiology expert.\u0026nbsp;\u003cem\u003eIn re: Zantac (Ranitidine) Prods. Liab. Litig.\u003c/em\u003e, 20-MD-2924, 2022 WL 17480906 (S.D. Fla., December 6, 2022).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in federal multidistrict litigation relating to allegations of birth defects from an anti-emetic medication. Deposed plaintiffs\u0026rsquo; main causation experts to obtain key admissions to support pending\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;challenges to exclude the experts\u0026rsquo; opinions. Successfully briefed motions related to an epidemiological study relied upon by plaintiffs\u0026rsquo; experts, revealing undisclosed conflicts of interest, including funding of the study by plaintiffs\u0026rsquo; counsel.\u0026nbsp;\u003cem\u003eIn re: Zofran (Ondansetron) Prods. Liab. Litig.\u003c/em\u003e, 392 F.Supp.3d 179 (D. Mass. 2019),\u0026nbsp;\u003cem\u003eIn re: Zofran (Ondansetron) Prods. Liab. Litig.\u003c/em\u003e, No. 1:15-md-2657, 2020 WL 1550563 (D. Mass. Apr. 1, 2020).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in federal and state litigation relating to allegations of birth defects from an anti-depressant medication. Successfully briefed\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;motion excluding plaintiffs\u0026rsquo; general and specific causation experts\u003cem\u003e. Frischhertz v. SmithKline Beecham Corp\u003c/em\u003e., No. CIV.A.10-2125, 2012 WL 6697124 (E.D. La. Dec. 21, 2012).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in state and federal litigation relating to allegations of neurological injuries from a denture adhesive product.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in multidistrict litigation relating to allegations of heart attack and stroke from an anti-diabetic medication.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":1,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":2,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":607,"guid":"607.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"Canaan","nick_name":"Eva","clerkships":[],"first_name":"Eva","title_rank":9999,"updated_by":202,"law_schools":[{"id":2619,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2003-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named New York Metro Super Lawyers®","detail":"Rising Star, 2014"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eEva Canaan\u0026rsquo;s practice focuses on the strategic development and coordination of the scientific defense in pharmaceutical and medical device products liability litigation. In addition to her law degree, Eva holds a Masters in Epidemiology from Columbia University.\u0026nbsp; Eva is adept at challenging expert witness testimony in depositions and\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;briefs in federal and state courts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eEva focuses on making complex scientific concepts accessible to judges and juries.\u0026nbsp; She routinely works with experts in a variety of scientific disciplines, including epidemiology, toxicology, teratology, and clinical medicine.\u0026nbsp; Going beyond bottom-line conclusions, Eva aggressively interrogates the data and methodology of studies and reports, often exposing flaws and weaknesses glossed over by the authors and plaintiffs\u0026rsquo; experts.\u0026nbsp; She has deposed plaintiffs\u0026rsquo; main causation experts and drafted\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem\u003eFrye\u003c/em\u003e\u0026nbsp;briefs in high-stakes litigations affecting hundreds of cases.\u0026nbsp; Eva follows the epidemiological literature related to her clients\u0026rsquo; products \u0026ndash; both in and outside of the litigation context -- and provides real-time analyses and risk-assessments to her clients.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eRepresenting major pharmaceutical company in federal multidistrict and state court litigation relating to allegations of cancer from a heartburn medication. Leading all science and expert work, encompassing epidemiology, toxicology, oncology, gastroenterology, pharmacology and analytical chemistry. Successfully deposed, briefed, and argued\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;motion relating to Plaintiffs\u0026rsquo; main epidemiology expert.\u0026nbsp;\u003cem\u003eIn re: Zantac (Ranitidine) Prods. Liab. Litig.\u003c/em\u003e, 20-MD-2924, 2022 WL 17480906 (S.D. Fla., December 6, 2022).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in federal multidistrict litigation relating to allegations of birth defects from an anti-emetic medication. Deposed plaintiffs\u0026rsquo; main causation experts to obtain key admissions to support pending\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;challenges to exclude the experts\u0026rsquo; opinions. Successfully briefed motions related to an epidemiological study relied upon by plaintiffs\u0026rsquo; experts, revealing undisclosed conflicts of interest, including funding of the study by plaintiffs\u0026rsquo; counsel.\u0026nbsp;\u003cem\u003eIn re: Zofran (Ondansetron) Prods. Liab. Litig.\u003c/em\u003e, 392 F.Supp.3d 179 (D. Mass. 2019),\u0026nbsp;\u003cem\u003eIn re: Zofran (Ondansetron) Prods. Liab. Litig.\u003c/em\u003e, No. 1:15-md-2657, 2020 WL 1550563 (D. Mass. Apr. 1, 2020).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in federal and state litigation relating to allegations of birth defects from an anti-depressant medication. Successfully briefed\u0026nbsp;\u003cem\u003eDaubert\u003c/em\u003e\u0026nbsp;motion excluding plaintiffs\u0026rsquo; general and specific causation experts\u003cem\u003e. Frischhertz v. SmithKline Beecham Corp\u003c/em\u003e., No. CIV.A.10-2125, 2012 WL 6697124 (E.D. La. Dec. 21, 2012).\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in state and federal litigation relating to allegations of neurological injuries from a denture adhesive product.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emajor pharmaceutical company\u003c/strong\u003e\u0026nbsp;in multidistrict litigation relating to allegations of heart attack and stroke from an anti-diabetic medication.\u003c/p\u003e"],"recognitions":[{"title":"Named New York Metro Super Lawyers®","detail":"Rising Star, 2014"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7829}]},"capability_group_id":3},"created_at":"2025-11-13T04:57:52.000Z","updated_at":"2025-11-13T04:57:52.000Z","searchable_text":"Canaan{{ FIELD }}{:title=\u0026gt;\"Named New York Metro Super Lawyers®\", :detail=\u0026gt;\"Rising Star, 2014\"}{{ FIELD }}Representing major pharmaceutical company in federal multidistrict and state court litigation relating to allegations of cancer from a heartburn medication. Leading all science and expert work, encompassing epidemiology, toxicology, oncology, gastroenterology, pharmacology and analytical chemistry. Successfully deposed, briefed, and argued Daubert motion relating to Plaintiffs’ main epidemiology expert. In re: Zantac (Ranitidine) Prods. Liab. Litig., 20-MD-2924, 2022 WL 17480906 (S.D. Fla., December 6, 2022).{{ FIELD }}Represented a major pharmaceutical company in federal multidistrict litigation relating to allegations of birth defects from an anti-emetic medication. Deposed plaintiffs’ main causation experts to obtain key admissions to support pending Daubert challenges to exclude the experts’ opinions. Successfully briefed motions related to an epidemiological study relied upon by plaintiffs’ experts, revealing undisclosed conflicts of interest, including funding of the study by plaintiffs’ counsel. In re: Zofran (Ondansetron) Prods. Liab. Litig., 392 F.Supp.3d 179 (D. Mass. 2019), In re: Zofran (Ondansetron) Prods. Liab. Litig., No. 1:15-md-2657, 2020 WL 1550563 (D. Mass. Apr. 1, 2020).{{ FIELD }}Represented a major pharmaceutical company in federal and state litigation relating to allegations of birth defects from an anti-depressant medication. Successfully briefed Daubert motion excluding plaintiffs’ general and specific causation experts. Frischhertz v. SmithKline Beecham Corp., No. CIV.A.10-2125, 2012 WL 6697124 (E.D. La. Dec. 21, 2012).{{ FIELD }}Represented a major pharmaceutical company in state and federal litigation relating to allegations of neurological injuries from a denture adhesive product.{{ FIELD }}Represented a major pharmaceutical company in multidistrict litigation relating to allegations of heart attack and stroke from an anti-diabetic medication.{{ FIELD }}Eva Canaan’s practice focuses on the strategic development and coordination of the scientific defense in pharmaceutical and medical device products liability litigation. In addition to her law degree, Eva holds a Masters in Epidemiology from Columbia University.  Eva is adept at challenging expert witness testimony in depositions and Daubert briefs in federal and state courts.\nEva focuses on making complex scientific concepts accessible to judges and juries.  She routinely works with experts in a variety of scientific disciplines, including epidemiology, toxicology, teratology, and clinical medicine.  Going beyond bottom-line conclusions, Eva aggressively interrogates the data and methodology of studies and reports, often exposing flaws and weaknesses glossed over by the authors and plaintiffs’ experts.  She has deposed plaintiffs’ main causation experts and drafted Daubert and Frye briefs in high-stakes litigations affecting hundreds of cases.  Eva follows the epidemiological literature related to her clients’ products – both in and outside of the litigation context -- and provides real-time analyses and risk-assessments to her clients.   Partner Named New York Metro Super Lawyers® Rising Star, 2014 New York University New York University School of Law Yeshiva University Benjamin N. Cardozo School of Law Columbia University Columbia University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York New York State Bar Association - Torts, Insurance and Compensation Law Section Representing major pharmaceutical company in federal multidistrict and state court litigation relating to allegations of cancer from a heartburn medication. Leading all science and expert work, encompassing epidemiology, toxicology, oncology, gastroenterology, pharmacology and analytical chemistry. Successfully deposed, briefed, and argued Daubert motion relating to Plaintiffs’ main epidemiology expert. In re: Zantac (Ranitidine) Prods. Liab. Litig., 20-MD-2924, 2022 WL 17480906 (S.D. Fla., December 6, 2022). Represented a major pharmaceutical company in federal multidistrict litigation relating to allegations of birth defects from an anti-emetic medication. Deposed plaintiffs’ main causation experts to obtain key admissions to support pending Daubert challenges to exclude the experts’ opinions. Successfully briefed motions related to an epidemiological study relied upon by plaintiffs’ experts, revealing undisclosed conflicts of interest, including funding of the study by plaintiffs’ counsel. In re: Zofran (Ondansetron) Prods. Liab. Litig., 392 F.Supp.3d 179 (D. Mass. 2019), In re: Zofran (Ondansetron) Prods. Liab. Litig., No. 1:15-md-2657, 2020 WL 1550563 (D. Mass. Apr. 1, 2020). Represented a major pharmaceutical company in federal and state litigation relating to allegations of birth defects from an anti-depressant medication. Successfully briefed Daubert motion excluding plaintiffs’ general and specific causation experts. Frischhertz v. SmithKline Beecham Corp., No. CIV.A.10-2125, 2012 WL 6697124 (E.D. La. Dec. 21, 2012). Represented a major pharmaceutical company in state and federal litigation relating to allegations of neurological injuries from a denture adhesive product. Represented a major pharmaceutical company in multidistrict litigation relating to allegations of heart attack and stroke from an anti-diabetic medication.","searchable_name":"Eva Canaan","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442354,"version":1,"owner_type":"Person","owner_id":121,"payload":{"bio":"\u003cp\u003eJack Capers is a partner focused on corporate transactions for companies in the technology and life sciences industries. He advises these companies on a broad range of domestic and cross-border corporate transactions including mergers, acquisitions, dispositions, joint ventures, strategic alliances and strategic investments, complex in-licensing and out-licensing transactions, collaboration and development agreements, and commercial contracts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe also represents clients in the consumer products, retail, industrial and manufacturing, real estate, food and beverage, telecommunications and transportation industries in corporate transactions. In addition, Jack advises boards of directors and board committees on corporate governance, M\u0026amp;A transactions, and takeover defenses.\u003c/p\u003e\n\u003cp\u003eA frequent speaker and author, Jack addresses important topics and trends in M\u0026amp;A and other corporate matters, bringing clients a valuable perspective that allows then to get the most out of their transactions.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch5\u003eAdmitted only in Georgia.\u003c/h5\u003e","slug":"jack-capers","email":"jcapers@kslaw.com","phone":"+1 404 307 6092","matters":["\u003cp\u003eRepresented \u003cstrong\u003eEisai Pharmaceuticals\u003c/strong\u003e in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer\u0026rsquo;s and related commercial arrangements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eBelk Stores,\u003c/strong\u003e a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eAurrion,\u003c/strong\u003e a developer of silicon photonics, in the sale of the company to Juniper Networks.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eCognea Pty,\u003c/strong\u003e a developer of artificial intelligence software and technology, in the sale of the company to IBM.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eArbor Pharmaceuticals,\u003c/strong\u003e a specialty pharmaceutical company, in a control investment in the company by KKR.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for \u0026pound;200 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eInmar,\u003c/strong\u003e a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eImmucor,\u003c/strong\u003e a blood diagnostics company, in its US$1.9 million merger with TPG.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":76}]},"expertise":[{"id":32,"guid":"32.capabilities","index":0,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":3,"source":"capabilities"},{"id":26,"guid":"26.capabilities","index":4,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":7,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":8,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":9,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":10,"source":"smartTags"},{"id":126,"guid":"126.capabilities","index":11,"source":"capabilities"},{"id":1220,"guid":"1220.smart_tags","index":12,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":13,"source":"smartTags"},{"id":1233,"guid":"1233.smart_tags","index":14,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":15,"source":"capabilities"}],"is_active":true,"last_name":"Capers","nick_name":"Jack","clerkships":[],"first_name":"Jack","title_rank":9999,"updated_by":35,"law_schools":[{"id":2190,"meta":{"degree":"J.D.","honors":"Order of the Coif","is_law_school":1,"graduation_date":"1978-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named a leading lawyer for M\u0026A and Corporate Law ","detail":"Best Lawyers, 2022"},{"title":"Notable Lawyer","detail":"IFLR 1000, 2020"},{"title":"Life Sciences Star in Mergers \u0026 Acquisitions","detail":"LMG Life Sciences"},{"title":"The Best Lawyers in America","detail":"Chambers"},{"title":"America’s Leading Lawyers for Business","detail":"Chambers USA"},{"title":"Georgia Super Lawyer","detail":"Atlanta Magazine"}],"linked_in_url":"https://www.linkedin.com/in/jackcapers/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJack Capers is a partner focused on corporate transactions for companies in the technology and life sciences industries. He advises these companies on a broad range of domestic and cross-border corporate transactions including mergers, acquisitions, dispositions, joint ventures, strategic alliances and strategic investments, complex in-licensing and out-licensing transactions, collaboration and development agreements, and commercial contracts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe also represents clients in the consumer products, retail, industrial and manufacturing, real estate, food and beverage, telecommunications and transportation industries in corporate transactions. In addition, Jack advises boards of directors and board committees on corporate governance, M\u0026amp;A transactions, and takeover defenses.\u003c/p\u003e\n\u003cp\u003eA frequent speaker and author, Jack addresses important topics and trends in M\u0026amp;A and other corporate matters, bringing clients a valuable perspective that allows then to get the most out of their transactions.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003ch5\u003eAdmitted only in Georgia.\u003c/h5\u003e","matters":["\u003cp\u003eRepresented \u003cstrong\u003eEisai Pharmaceuticals\u003c/strong\u003e in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer\u0026rsquo;s and related commercial arrangements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eBelk Stores,\u003c/strong\u003e a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eAurrion,\u003c/strong\u003e a developer of silicon photonics, in the sale of the company to Juniper Networks.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eCognea Pty,\u003c/strong\u003e a developer of artificial intelligence software and technology, in the sale of the company to IBM.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eArbor Pharmaceuticals,\u003c/strong\u003e a specialty pharmaceutical company, in a control investment in the company by KKR.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for \u0026pound;200 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eInmar,\u003c/strong\u003e a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eImmucor,\u003c/strong\u003e a blood diagnostics company, in its US$1.9 million merger with TPG.\u003c/p\u003e"],"recognitions":[{"title":"Named a leading lawyer for M\u0026A and Corporate Law ","detail":"Best Lawyers, 2022"},{"title":"Notable Lawyer","detail":"IFLR 1000, 2020"},{"title":"Life Sciences Star in Mergers \u0026 Acquisitions","detail":"LMG Life Sciences"},{"title":"The Best Lawyers in America","detail":"Chambers"},{"title":"America’s Leading Lawyers for Business","detail":"Chambers USA"},{"title":"Georgia Super Lawyer","detail":"Atlanta Magazine"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12159}]},"capability_group_id":1},"created_at":"2025-11-05T05:03:21.000Z","updated_at":"2025-11-05T05:03:21.000Z","searchable_text":"Capers{{ FIELD }}{:title=\u0026gt;\"Named a leading lawyer for M\u0026amp;A and Corporate Law \", :detail=\u0026gt;\"Best Lawyers, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Notable Lawyer\", :detail=\u0026gt;\"IFLR 1000, 2020\"}{{ FIELD }}{:title=\u0026gt;\"Life Sciences Star in Mergers \u0026amp; Acquisitions\", :detail=\u0026gt;\"LMG Life Sciences\"}{{ FIELD }}{:title=\u0026gt;\"The Best Lawyers in America\", :detail=\u0026gt;\"Chambers\"}{{ FIELD }}{:title=\u0026gt;\"America’s Leading Lawyers for Business\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Georgia Super Lawyer\", :detail=\u0026gt;\"Atlanta Magazine\"}{{ FIELD }}Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements.{{ FIELD }}Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.{{ FIELD }}Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks.{{ FIELD }}Represented Cognea Pty, a developer of artificial intelligence software and technology, in the sale of the company to IBM.{{ FIELD }}Represented Arbor Pharmaceuticals, a specialty pharmaceutical company, in a control investment in the company by KKR.{{ FIELD }}Represented GlaxoSmithKline in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for £200 million.{{ FIELD }}Represented GlaxoSmithKline in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million.{{ FIELD }}Represented Inmar, a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data.{{ FIELD }}Represented Immucor, a blood diagnostics company, in its US$1.9 million merger with TPG.{{ FIELD }}Jack Capers is a partner focused on corporate transactions for companies in the technology and life sciences industries. He advises these companies on a broad range of domestic and cross-border corporate transactions including mergers, acquisitions, dispositions, joint ventures, strategic alliances and strategic investments, complex in-licensing and out-licensing transactions, collaboration and development agreements, and commercial contracts.\nHe also represents clients in the consumer products, retail, industrial and manufacturing, real estate, food and beverage, telecommunications and transportation industries in corporate transactions. In addition, Jack advises boards of directors and board committees on corporate governance, M\u0026amp;A transactions, and takeover defenses.\nA frequent speaker and author, Jack addresses important topics and trends in M\u0026amp;A and other corporate matters, bringing clients a valuable perspective that allows then to get the most out of their transactions.\n \nAdmitted only in Georgia. Jack D Capers Partner Named a leading lawyer for M\u0026amp;A and Corporate Law  Best Lawyers, 2022 Notable Lawyer IFLR 1000, 2020 Life Sciences Star in Mergers \u0026amp; Acquisitions LMG Life Sciences The Best Lawyers in America Chambers America’s Leading Lawyers for Business Chambers USA Georgia Super Lawyer Atlanta Magazine Vanderbilt University Vanderbilt University School of Law University of Georgia University of Georgia School of Law California Georgia American Bar Association Best Lawyers In America State Bar of Georgia Atlanta Bar Association California Bar Association Chambers Ranked IFLR 1000 LMG Life Sciences Star Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements. Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion. Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks. Represented Cognea Pty, a developer of artificial intelligence software and technology, in the sale of the company to IBM. Represented Arbor Pharmaceuticals, a specialty pharmaceutical company, in a control investment in the company by KKR. Represented GlaxoSmithKline in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for £200 million. Represented GlaxoSmithKline in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million. Represented Inmar, a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data. Represented Immucor, a blood diagnostics company, in its US$1.9 million merger with TPG.","searchable_name":"Jack Capers","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":426829,"version":1,"owner_type":"Person","owner_id":5863,"payload":{"bio":"\u003cp\u003eChristine M. Carletta is a\u0026nbsp;partner in the Washington, D.C. office of King \u0026amp; Spalding. As\u0026nbsp;a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients\u0026rsquo; objectives through all phases of litigation and appeal. Christine\u0026rsquo;s extensive experience covers a broad range of subjects including\u0026nbsp;Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and\u0026nbsp;class actions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of\u0026nbsp;the Vanderbilt Journal of Entertainment and Technology Law.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"christine-carletta","email":"ccarletta@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":3,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":8,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":11,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Carletta","nick_name":"Christine","clerkships":[{"name":"Law Clerk, The Honorable Chad A. Readler, U.S. Court of Appeals for the Sixth Circuit","years_held":"2019 - 2020"},{"name":"Law Clerk, The Honorable James C. Mahan, U.S. District Court for the District of Nevada","years_held":"2015 - 2016"}],"first_name":"Christine","title_rank":9999,"updated_by":32,"law_schools":[{"id":2442,"meta":{"degree":"Juris Doctor","honors":"","is_law_school":"1","graduation_date":"2015-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChristine M. Carletta is a\u0026nbsp;partner in the Washington, D.C. office of King \u0026amp; Spalding. As\u0026nbsp;a member of the firm\u0026rsquo;s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients\u0026rsquo; objectives through all phases of litigation and appeal. Christine\u0026rsquo;s extensive experience covers a broad range of subjects including\u0026nbsp;Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and\u0026nbsp;class actions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of\u0026nbsp;the Vanderbilt Journal of Entertainment and Technology Law.\u0026nbsp;\u0026nbsp;\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9711}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:14.000Z","updated_at":"2025-05-26T04:57:14.000Z","searchable_text":"Carletta{{ FIELD }}Christine M. Carletta is a partner in the Washington, D.C. office of King \u0026amp; Spalding. As a member of the firm’s Appellate, Constitutional, and Administrative Law practice group, Christine develops creative litigation strategies to best serve her clients’ objectives through all phases of litigation and appeal. Christine’s extensive experience covers a broad range of subjects including Medicare and Medicaid regulation, Food and Drug Administration regulation, the False Claims Act, fraud and abuse matters, state and federal privacy laws, securities regulations, contract disputes, consumer protection claims, and class actions. \nPrior to joining King \u0026amp; Spalding, Christine served as a law clerk to the Honorable Chad A Readler, United States Court of Appeals for the Sixth Circuit and the Honorable James C. Mahan, United States District Court for the District of Nevada. She received her J.D. from Vanderbilt Law School, where she served as Editor-in-Chief of the Vanderbilt Journal of Entertainment and Technology Law.   Partner Bowdoin College  Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Tenth Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Northern District of Illinois District of Columbia New York Law Clerk, The Honorable Chad A. Readler, U.S. Court of Appeals for the Sixth Circuit Law Clerk, The Honorable James C. Mahan, U.S. District Court for the District of Nevada","searchable_name":"Christine Carletta","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":446321,"version":1,"owner_type":"Person","owner_id":5906,"payload":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","slug":"craig-carpenito","email":"ccarpenito@kslaw.com","phone":"","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":8,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":9,"source":"smartTags"},{"id":120,"guid":"120.capabilities","index":10,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":11,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":12,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":13,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":14,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":15,"source":"capabilities"},{"id":803,"guid":"803.smart_tags","index":16,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":17,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":18,"source":"smartTags"}],"is_active":true,"last_name":"Carpenito","nick_name":"Craig","clerkships":[],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":1790,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2000-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}],"linked_in_url":"https://www.linkedin.com/in/craig-carpenito-a3269612/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8527}]},"capability_group_id":2},"created_at":"2026-03-02T21:59:43.000Z","updated_at":"2026-03-02T21:59:43.000Z","searchable_text":"Carpenito{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described as \\\"an outstanding attorney and seasoned white-collar adviser\\\" that is “extremely dedicated to his clients”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"\\\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described by a healthcare client as having \\\"deep subject matter knowledge.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading financial services lawyer \\\"with extensive governmental and regulatory expertise.\\\"\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in white-collar defense and government/internal investigations\", :detail=\u0026gt;\"Law360, 2012\"}{{ FIELD }}{:title=\u0026gt;\"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018\", :detail=\u0026gt;\"Super Lawyers\"}{{ FIELD }}Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.{{ FIELD }}Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.{{ FIELD }}Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.{{ FIELD }}Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.{{ FIELD }}Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.{{ FIELD }}Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.{{ FIELD }}Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.{{ FIELD }}Former U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding’s Special Matters \u0026amp; Government Investigations practice. Craig’s experience heading one of the nation’s largest U.S. Attorney’s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients’ most complex and sensitive problems.  Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.\nImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.  As U.S. Attorney, Craig made significant organizational changes, including creating the nation’s first standalone opioid enforcement unit and the District’s first cybercrimes unit.  Craig also expanded the  number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.   In August 2018, working with DOJ’s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey. \nDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ’s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.  In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.  Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ’s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.  He was a member of the Attorney General’s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\nPrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm’s litigation and trial practice group and also led its white collar, government and internal investigations team.  Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC’s Office of International Affairs and the UK’s Financial Conduct Authority and Serious Fraud Office.  Craig also represented clients in complex civil litigations and trials in federal and state courts.\nEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.  Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission’s Division of Enforcement.\nRecent Publication:Co-authored a chapter in PLI’s SEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations Partner Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare Chambers USA Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients” Chambers USA \"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\" Chambers USA Described by a healthcare client as having \"deep subject matter knowledge.\" Chambers USA Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\" Legal 500 Named a Rising Star in white-collar defense and government/internal investigations Law360, 2012 Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018 Super Lawyers Rider University  Seton Hall University Seton Hall University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Western District of New York U.S. District Court for the District of New Jersey New Jersey New York American Bar Association National Association of Former United States Attorneys (NAFUSA) The New York Council of Defense Lawyers (NYCDL) The Association of Criminal Defense Lawyers of New Jersey New Jersey Reentry Corporation Training Center Board of Trustees New York State Bar Association New Jersey State Bar Association Association of the Federal Bar of New Jersey (Advisory Committee Member) SIFMA, Legal and Compliance Division Association of Securities and Exchange Commission Alumni The United States Attorney’s Office for the District of New Jersey Alumni Association United States District Court for the District of New Jersey Lawyer’s Advisory Committee Seton Hall University School of Law Board of Visitors Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations. Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices. Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice. Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix. Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client. Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices. Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations. Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC. Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets. Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.","searchable_name":"Craig Carpenito","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":442988,"version":1,"owner_type":"Person","owner_id":2849,"payload":{"bio":"\u003cp\u003eJohn Carroll is a partner in King \u0026amp; Spalding\u0026rsquo;s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John\u0026rsquo;s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to private practice, John was in the Mergers I Division of the Federal Trade Commission\u0026rsquo;s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\u003c/p\u003e\n\u003cp\u003eJohn has been recognized by leading publications such as \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eBest Lawyers\u003c/em\u003e and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries.\u003c/p\u003e","slug":"john-carroll","email":"jdcarroll@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eHealthcare \u0026amp; Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.\u003c/p\u003e","\u003cp\u003eLed antitrust efforts for VillageMD in achieving antitrust clearance for its\u0026nbsp;$8.9 billion acquisition of Summit Health.\u003c/p\u003e","\u003cp\u003eSuccessfully represented clinically and financially integrated provider networks in nonpublic government investigations.\u003c/p\u003e","\u003cp\u003eAdvising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.\u003c/p\u003e","\u003cp\u003eAdvising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eConsumer Products \u0026amp; Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.\u003c/p\u003e","\u003cp\u003eAdvises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.\u003c/p\u003e","\u003cp\u003eRepresented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation\u0026rsquo;s largest movie theatre chain.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.\u003c/p\u003e","\u003cp\u003eAdvising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.\u003c/p\u003e","\u003cp\u003eDevised and implemented antitrust compliance strategies for coalitions of energy industry competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented leading chemical and building products companies in transactions and defended them in government investigations.\u003c/p\u003e","\u003cp\u003eRepresented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGlobal Cartel Investigations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multinational companies in criminal investigations alleging antitrust conspiracies.\u003c/p\u003e","\u003cp\u003eRepresented an executive of international auto parts company in connection with a cartel investigation in that industry.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":4,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":8,"source":"capabilities"},{"id":1147,"guid":"1147.smart_tags","index":9,"source":"smartTags"},{"id":687,"guid":"687.smart_tags","index":10,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Carroll","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":34,"law_schools":[],"middle_name":"","name_suffix":"","recognitions":[{"title":"Top Author","detail":"JD Supra Readers’ Choice Awards, 2025"},{"title":"Best Lawyers: Ones to Watch","detail":"Best Lawyers, 2023-2024"},{"title":"Recommended Lawyers – Antitrust","detail":"Legal 500, 2022-2025"},{"title":"Leading Lawyer – Antitrust","detail":"Legal 500, 2020"},{"title":"Rising Star – Antitrust","detail":"Washington Super Lawyers, 2016"}],"linked_in_url":"https://www.linkedin.com/in/john-carroll-1384a022/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Carroll is a partner in King \u0026amp; Spalding\u0026rsquo;s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John\u0026rsquo;s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to private practice, John was in the Mergers I Division of the Federal Trade Commission\u0026rsquo;s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\u003c/p\u003e\n\u003cp\u003eJohn has been recognized by leading publications such as \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eBest Lawyers\u003c/em\u003e and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eHealthcare \u0026amp; Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.\u003c/p\u003e","\u003cp\u003eLed antitrust efforts for VillageMD in achieving antitrust clearance for its\u0026nbsp;$8.9 billion acquisition of Summit Health.\u003c/p\u003e","\u003cp\u003eSuccessfully represented clinically and financially integrated provider networks in nonpublic government investigations.\u003c/p\u003e","\u003cp\u003eAdvising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.\u003c/p\u003e","\u003cp\u003eAdvising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eConsumer Products \u0026amp; Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.\u003c/p\u003e","\u003cp\u003eAdvises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.\u003c/p\u003e","\u003cp\u003eRepresented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation\u0026rsquo;s largest movie theatre chain.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.\u003c/p\u003e","\u003cp\u003eAdvising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.\u003c/p\u003e","\u003cp\u003eDevised and implemented antitrust compliance strategies for coalitions of energy industry competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented leading chemical and building products companies in transactions and defended them in government investigations.\u003c/p\u003e","\u003cp\u003eRepresented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGlobal Cartel Investigations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multinational companies in criminal investigations alleging antitrust conspiracies.\u003c/p\u003e","\u003cp\u003eRepresented an executive of international auto parts company in connection with a cartel investigation in that industry.\u003c/p\u003e"],"recognitions":[{"title":"Top Author","detail":"JD Supra Readers’ Choice Awards, 2025"},{"title":"Best Lawyers: Ones to Watch","detail":"Best Lawyers, 2023-2024"},{"title":"Recommended Lawyers – Antitrust","detail":"Legal 500, 2022-2025"},{"title":"Leading Lawyer – Antitrust","detail":"Legal 500, 2020"},{"title":"Rising Star – Antitrust","detail":"Washington Super Lawyers, 2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13154}]},"capability_group_id":2},"created_at":"2025-11-17T21:52:05.000Z","updated_at":"2025-11-17T21:52:05.000Z","searchable_text":"Carroll{{ FIELD }}{:title=\u0026gt;\"Top Author\", :detail=\u0026gt;\"JD Supra Readers’ Choice Awards, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers: Ones to Watch\", :detail=\u0026gt;\"Best Lawyers, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyers – Antitrust\", :detail=\u0026gt;\"Legal 500, 2022-2025\"}{{ FIELD }}{:title=\u0026gt;\"Leading Lawyer – Antitrust\", :detail=\u0026gt;\"Legal 500, 2020\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star – Antitrust\", :detail=\u0026gt;\"Washington Super Lawyers, 2016\"}{{ FIELD }}Healthcare \u0026amp; Life Sciences\nServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.{{ FIELD }}Led antitrust efforts for VillageMD in achieving antitrust clearance for its $8.9 billion acquisition of Summit Health.{{ FIELD }}Successfully represented clinically and financially integrated provider networks in nonpublic government investigations.{{ FIELD }}Advising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.{{ FIELD }}Advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.{{ FIELD }}Consumer Products \u0026amp; Entertainment\nRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.{{ FIELD }}Advises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.{{ FIELD }}Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.{{ FIELD }}Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain.{{ FIELD }}Energy\nRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.{{ FIELD }}Advising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.{{ FIELD }}Successfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.{{ FIELD }}Devised and implemented antitrust compliance strategies for coalitions of energy industry competitors.{{ FIELD }}Manufacturing\nRepresented leading chemical and building products companies in transactions and defended them in government investigations.{{ FIELD }}Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.{{ FIELD }}Global Cartel Investigations\nDefended multinational companies in criminal investigations alleging antitrust conspiracies.{{ FIELD }}Represented an executive of international auto parts company in connection with a cartel investigation in that industry.{{ FIELD }}John Carroll is a partner in King \u0026amp; Spalding’s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John’s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. \nPrior to private practice, John was in the Mergers I Division of the Federal Trade Commission’s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\nJohn has been recognized by leading publications such as Legal 500 and Best Lawyers and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries. Partner Top Author JD Supra Readers’ Choice Awards, 2025 Best Lawyers: Ones to Watch Best Lawyers, 2023-2024 Recommended Lawyers – Antitrust Legal 500, 2022-2025 Leading Lawyer – Antitrust Legal 500, 2020 Rising Star – Antitrust Washington Super Lawyers, 2016 University of Michigan University of Michigan Law School George Washington University George Washington University Law School Supreme Court of the United States District of Columbia Maryland ABA Antitrust Section, Vice-Chair of the Media \u0026amp; Technologies Committee (2021-2022, 2022-2023) Healthcare \u0026amp; Life Sciences\nServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews. Led antitrust efforts for VillageMD in achieving antitrust clearance for its $8.9 billion acquisition of Summit Health. Successfully represented clinically and financially integrated provider networks in nonpublic government investigations. Advising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions. Advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures. Consumer Products \u0026amp; Entertainment\nRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues. Advises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution. Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands. Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain. Energy\nRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor. Advising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations. Successfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action. Devised and implemented antitrust compliance strategies for coalitions of energy industry competitors. Manufacturing\nRepresented leading chemical and building products companies in transactions and defended them in government investigations. Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging. Global Cartel Investigations\nDefended multinational companies in criminal investigations alleging antitrust conspiracies. Represented an executive of international auto parts company in connection with a cartel investigation in that industry.","searchable_name":"John Carroll","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":426813,"version":1,"owner_type":"Person","owner_id":5707,"payload":{"bio":"\u003cp\u003eSteve Cave is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters and Government Investigations practice. \u0026nbsp;\u0026nbsp;He represents a wide variety of government contractors including those specializing in defense, consulting, and information technology.\u0026nbsp; Steve\u0026rsquo;s focus is on government contract counseling and compliance, and transactional support.\u0026nbsp; Steve has led numerous internal investigations and served as primary counsel during mergers and acquisitions involving government contractors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eSteve regularly counsels contractors on risks arising under laws and regulations applicable to contracting with federal, state, and local government entities.\u0026nbsp; He has in-depth experience leading and managing internal investigations and risk reviews as both in-house counsel, and external counsel.\u0026nbsp; As a former in-house attorney for a leading consulting company, Steve has unique perspectives that help companies quickly dissect and assess relevant risks, and make informed decisions.\u003c/p\u003e\n\u003cp\u003eSteve represents government contractors in all phases of government contracts including performance, compliance and dispute resolution. Steve serves as the primary government contracts counsel and transactional attorney representing industry leaders, private equity firms, and entrepreneurs that range from major public companies to start-ups.\u0026nbsp; He has in-depth experience in leading M\u0026amp;A transactions for defense sector clients and has represented clients ranging from start-ups to major public companies.\u003c/p\u003e\n\u003cp\u003eSteve has extensive experience developing and negotiating complex agreements during acquisitions, and counseling on related issues including national security, intellectual property and data rights, business size, and anti-corruption.\u003c/p\u003e\n\u003cp\u003eSteve also serves as counsel in high-stakes litigation, including pre- and post-award protests at the GAO, the U.S. Court of Federal Claims, and various state tribunals, and size protests and appeals.\u0026nbsp; Steve also has extensive experience handling litigation related to the Freedom of Information Act and various open records laws in states and localities.\u003c/p\u003e","slug":"steven-cave","email":"scave@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented Space Exploration Technologies Corp. (SpaceX) in defeating Sierra Nevada Corp.\u0026rsquo;s bid protest filed at GAO challenging NASA\u0026rsquo;s $2.6 billion contract award for the development of a new spacecraft capable of replacing the Space Shuttle and transporting astronauts to and from the International Space Station.\u003c/p\u003e","\u003cp\u003eRepresented large defense contractors in numerous mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eRepresented numerous General Services Administration Federal Supply Schedule contractors in investigating False Claims Act allegations and successfully resolving or settling the allegations.\u003c/p\u003e","\u003cp\u003eRepresented Prism Maritime LLC in in a successful post-award bid protest at GAO challenging the Navy\u0026rsquo;s improper award decision of a $46 million contract.\u003c/p\u003e","\u003cp\u003eRepresented small business in size protest successfully defending against a challenge to its small business size status due to an acquisition by private equity firm.\u003c/p\u003e","\u003cp\u003eRepresented company in a \u0026ldquo;reverse\u0026rdquo; Freedom of Information Act case in federal court that resulted in favorable settlement of outstanding request for information.\u003c/p\u003e","\u003cp\u003eRepresented a company in numerous \u0026ldquo;reverse\u0026rdquo; public records act cases at various state and local levels to ensure that the contractor\u0026rsquo;s exempt information remained confidential.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":4,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":5,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":6,"source":"smartTags"},{"id":763,"guid":"763.smart_tags","index":7,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":8,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":9,"source":"smartTags"},{"id":116,"guid":"116.capabilities","index":10,"source":"capabilities"},{"id":1142,"guid":"1142.smart_tags","index":11,"source":"smartTags"},{"id":110,"guid":"110.capabilities","index":12,"source":"capabilities"},{"id":120,"guid":"120.capabilities","index":13,"source":"capabilities"},{"id":1178,"guid":"1178.smart_tags","index":14,"source":"smartTags"},{"id":121,"guid":"121.capabilities","index":15,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":16,"source":"capabilities"},{"id":124,"guid":"124.capabilities","index":17,"source":"capabilities"},{"id":1219,"guid":"1219.smart_tags","index":18,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":19,"source":"capabilities"}],"is_active":true,"last_name":"Cave","nick_name":"Steve","clerkships":[],"first_name":"Steve","title_rank":9999,"updated_by":101,"law_schools":[{"id":752,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2010-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"Steve has the unique ability to distill issues in a meaningful and creative manner” and is “attentive to client needs.\"","detail":"Chambers USA (2022)"},{"title":"Top Ranked Lawyer, Government Contracts","detail":"Chambers USA, Nationwide (2021-2022)"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSteve Cave is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters and Government Investigations practice. \u0026nbsp;\u0026nbsp;He represents a wide variety of government contractors including those specializing in defense, consulting, and information technology.\u0026nbsp; Steve\u0026rsquo;s focus is on government contract counseling and compliance, and transactional support.\u0026nbsp; Steve has led numerous internal investigations and served as primary counsel during mergers and acquisitions involving government contractors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eSteve regularly counsels contractors on risks arising under laws and regulations applicable to contracting with federal, state, and local government entities.\u0026nbsp; He has in-depth experience leading and managing internal investigations and risk reviews as both in-house counsel, and external counsel.\u0026nbsp; As a former in-house attorney for a leading consulting company, Steve has unique perspectives that help companies quickly dissect and assess relevant risks, and make informed decisions.\u003c/p\u003e\n\u003cp\u003eSteve represents government contractors in all phases of government contracts including performance, compliance and dispute resolution. Steve serves as the primary government contracts counsel and transactional attorney representing industry leaders, private equity firms, and entrepreneurs that range from major public companies to start-ups.\u0026nbsp; He has in-depth experience in leading M\u0026amp;A transactions for defense sector clients and has represented clients ranging from start-ups to major public companies.\u003c/p\u003e\n\u003cp\u003eSteve has extensive experience developing and negotiating complex agreements during acquisitions, and counseling on related issues including national security, intellectual property and data rights, business size, and anti-corruption.\u003c/p\u003e\n\u003cp\u003eSteve also serves as counsel in high-stakes litigation, including pre- and post-award protests at the GAO, the U.S. Court of Federal Claims, and various state tribunals, and size protests and appeals.\u0026nbsp; Steve also has extensive experience handling litigation related to the Freedom of Information Act and various open records laws in states and localities.\u003c/p\u003e","matters":["\u003cp\u003eRepresented Space Exploration Technologies Corp. (SpaceX) in defeating Sierra Nevada Corp.\u0026rsquo;s bid protest filed at GAO challenging NASA\u0026rsquo;s $2.6 billion contract award for the development of a new spacecraft capable of replacing the Space Shuttle and transporting astronauts to and from the International Space Station.\u003c/p\u003e","\u003cp\u003eRepresented large defense contractors in numerous mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eRepresented numerous General Services Administration Federal Supply Schedule contractors in investigating False Claims Act allegations and successfully resolving or settling the allegations.\u003c/p\u003e","\u003cp\u003eRepresented Prism Maritime LLC in in a successful post-award bid protest at GAO challenging the Navy\u0026rsquo;s improper award decision of a $46 million contract.\u003c/p\u003e","\u003cp\u003eRepresented small business in size protest successfully defending against a challenge to its small business size status due to an acquisition by private equity firm.\u003c/p\u003e","\u003cp\u003eRepresented company in a \u0026ldquo;reverse\u0026rdquo; Freedom of Information Act case in federal court that resulted in favorable settlement of outstanding request for information.\u003c/p\u003e","\u003cp\u003eRepresented a company in numerous \u0026ldquo;reverse\u0026rdquo; public records act cases at various state and local levels to ensure that the contractor\u0026rsquo;s exempt information remained confidential.\u003c/p\u003e"],"recognitions":[{"title":"\"Steve has the unique ability to distill issues in a meaningful and creative manner” and is “attentive to client needs.\"","detail":"Chambers USA (2022)"},{"title":"Top Ranked Lawyer, Government Contracts","detail":"Chambers USA, Nationwide (2021-2022)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7603}]},"capability_group_id":2},"created_at":"2025-05-26T04:57:04.000Z","updated_at":"2025-05-26T04:57:04.000Z","searchable_text":"Cave{{ FIELD }}{:title=\u0026gt;\"\\\"Steve has the unique ability to distill issues in a meaningful and creative manner” and is “attentive to client needs.\\\"\", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Government Contracts\", :detail=\u0026gt;\"Chambers USA, Nationwide (2021-2022)\"}{{ FIELD }}Represented Space Exploration Technologies Corp. (SpaceX) in defeating Sierra Nevada Corp.’s bid protest filed at GAO challenging NASA’s $2.6 billion contract award for the development of a new spacecraft capable of replacing the Space Shuttle and transporting astronauts to and from the International Space Station.{{ FIELD }}Represented large defense contractors in numerous mergers and acquisitions.{{ FIELD }}Represented numerous General Services Administration Federal Supply Schedule contractors in investigating False Claims Act allegations and successfully resolving or settling the allegations.{{ FIELD }}Represented Prism Maritime LLC in in a successful post-award bid protest at GAO challenging the Navy’s improper award decision of a $46 million contract.{{ FIELD }}Represented small business in size protest successfully defending against a challenge to its small business size status due to an acquisition by private equity firm.{{ FIELD }}Represented company in a “reverse” Freedom of Information Act case in federal court that resulted in favorable settlement of outstanding request for information.{{ FIELD }}Represented a company in numerous “reverse” public records act cases at various state and local levels to ensure that the contractor’s exempt information remained confidential.{{ FIELD }}Steve Cave is a partner in King \u0026amp; Spalding’s Special Matters and Government Investigations practice.   He represents a wide variety of government contractors including those specializing in defense, consulting, and information technology.  Steve’s focus is on government contract counseling and compliance, and transactional support.  Steve has led numerous internal investigations and served as primary counsel during mergers and acquisitions involving government contractors. \nSteve regularly counsels contractors on risks arising under laws and regulations applicable to contracting with federal, state, and local government entities.  He has in-depth experience leading and managing internal investigations and risk reviews as both in-house counsel, and external counsel.  As a former in-house attorney for a leading consulting company, Steve has unique perspectives that help companies quickly dissect and assess relevant risks, and make informed decisions.\nSteve represents government contractors in all phases of government contracts including performance, compliance and dispute resolution. Steve serves as the primary government contracts counsel and transactional attorney representing industry leaders, private equity firms, and entrepreneurs that range from major public companies to start-ups.  He has in-depth experience in leading M\u0026amp;A transactions for defense sector clients and has represented clients ranging from start-ups to major public companies.\nSteve has extensive experience developing and negotiating complex agreements during acquisitions, and counseling on related issues including national security, intellectual property and data rights, business size, and anti-corruption.\nSteve also serves as counsel in high-stakes litigation, including pre- and post-award protests at the GAO, the U.S. Court of Federal Claims, and various state tribunals, and size protests and appeals.  Steve also has extensive experience handling litigation related to the Freedom of Information Act and various open records laws in states and localities. Partner \"Steve has the unique ability to distill issues in a meaningful and creative manner” and is “attentive to client needs.\" Chambers USA (2022) Top Ranked Lawyer, Government Contracts Chambers USA, Nationwide (2021-2022) Virginia Polytechnic Institute and State University  George Mason University George Mason University School of Law U.S. Court of Federal Claims U.S. District Court for the Eastern District of Virginia District of Columbia Virginia Represented Space Exploration Technologies Corp. (SpaceX) in defeating Sierra Nevada Corp.’s bid protest filed at GAO challenging NASA’s $2.6 billion contract award for the development of a new spacecraft capable of replacing the Space Shuttle and transporting astronauts to and from the International Space Station. Represented large defense contractors in numerous mergers and acquisitions. Represented numerous General Services Administration Federal Supply Schedule contractors in investigating False Claims Act allegations and successfully resolving or settling the allegations. Represented Prism Maritime LLC in in a successful post-award bid protest at GAO challenging the Navy’s improper award decision of a $46 million contract. Represented small business in size protest successfully defending against a challenge to its small business size status due to an acquisition by private equity firm. Represented company in a “reverse” Freedom of Information Act case in federal court that resulted in favorable settlement of outstanding request for information. Represented a company in numerous “reverse” public records act cases at various state and local levels to ensure that the contractor’s exempt information remained confidential.","searchable_name":"Steve Cave","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":436410,"version":1,"owner_type":"Person","owner_id":3266,"payload":{"bio":"\u003cp\u003eWilliam Charnley specializes in a variety of corporate transactions, along with general corporate, private equity and securities advice. A partner in our Mergers \u0026amp; Acquisitions practice, William represents private equity, hedge funds, financial institutions, corporates and high-net-worth individuals.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWilliam counsels clients on public and private mergers and acquisitions, dispositions, flotations and similar issues, as well as on private equity transactions and corporate and securities matters. He works with clients in many industries, notably banking and insurance, financial services, telecommunications, technology, oil and gas, hospitality, infrastructure, entertainment and media.\u003c/p\u003e\n\u003cp\u003eConsistently ranked as a leading lawyer, William has been recognized in \u003cem\u003eChambers UK\u003c/em\u003e for many years, including in 2025 for Corporate/M\u0026amp;A. He has also been cited in various editions of \u003cem\u003eLegal 500,\u003c/em\u003e as well as in \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers Europe\u003c/em\u003e.\u003c/p\u003e","slug":"william-charnley","email":"wcharnley@kslaw.com","phone":"+44 77 8570 4598","matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":33,"guid":"33.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":26,"guid":"26.capabilities","index":2,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":6,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":7,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":8,"source":"smartTags"},{"id":1148,"guid":"1148.smart_tags","index":9,"source":"smartTags"},{"id":1192,"guid":"1192.smart_tags","index":10,"source":"smartTags"},{"id":123,"guid":"123.capabilities","index":11,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":12,"source":"capabilities"},{"id":1220,"guid":"1220.smart_tags","index":13,"source":"smartTags"}],"is_active":true,"last_name":"Charnley","nick_name":"William","clerkships":[],"first_name":"William","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"F.","name_suffix":"","recognitions":[{"title":"Chambers UK","detail":"2025"},{"title":"Chambers Europe","detail":"2025"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWilliam Charnley specializes in a variety of corporate transactions, along with general corporate, private equity and securities advice. A partner in our Mergers \u0026amp; Acquisitions practice, William represents private equity, hedge funds, financial institutions, corporates and high-net-worth individuals.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWilliam counsels clients on public and private mergers and acquisitions, dispositions, flotations and similar issues, as well as on private equity transactions and corporate and securities matters. He works with clients in many industries, notably banking and insurance, financial services, telecommunications, technology, oil and gas, hospitality, infrastructure, entertainment and media.\u003c/p\u003e\n\u003cp\u003eConsistently ranked as a leading lawyer, William has been recognized in \u003cem\u003eChambers UK\u003c/em\u003e for many years, including in 2025 for Corporate/M\u0026amp;A. He has also been cited in various editions of \u003cem\u003eLegal 500,\u003c/em\u003e as well as in \u003cem\u003eChambers Global\u003c/em\u003e and \u003cem\u003eChambers Europe\u003c/em\u003e.\u003c/p\u003e","recognitions":[{"title":"Chambers UK","detail":"2025"},{"title":"Chambers Europe","detail":"2025"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4577}]},"capability_group_id":1},"created_at":"2025-09-02T04:52:21.000Z","updated_at":"2025-09-02T04:52:21.000Z","searchable_text":"Charnley{{ FIELD }}{:title=\u0026gt;\"Chambers UK\", :detail=\u0026gt;\"2025\"}{{ FIELD }}{:title=\u0026gt;\"Chambers Europe\", :detail=\u0026gt;\"2025\"}{{ FIELD }}William Charnley specializes in a variety of corporate transactions, along with general corporate, private equity and securities advice. A partner in our Mergers \u0026amp; Acquisitions practice, William represents private equity, hedge funds, financial institutions, corporates and high-net-worth individuals.\nWilliam counsels clients on public and private mergers and acquisitions, dispositions, flotations and similar issues, as well as on private equity transactions and corporate and securities matters. He works with clients in many industries, notably banking and insurance, financial services, telecommunications, technology, oil and gas, hospitality, infrastructure, entertainment and media.\nConsistently ranked as a leading lawyer, William has been recognized in Chambers UK for many years, including in 2025 for Corporate/M\u0026amp;A. He has also been cited in various editions of Legal 500, as well as in Chambers Global and Chambers Europe. Partner Chambers UK 2025 Chambers Europe 2025 The Law Societyof England and Wales The Law Society of England and Wales (Admitted 1/10/1987; Reg. # 136662)","searchable_name":"William F. Charnley","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444009,"version":1,"owner_type":"Person","owner_id":7211,"payload":{"bio":"\u003cp\u003eNeel Chatterjee is an internationally recognized technology litigator and trial lawyer. He has a proven track record handling hard-to-win technology cases for some of the world\u0026rsquo;s leading companies and newest disruptive technology companies. His cases often break new ground in undefined areas of the law or are existential disputes for product lines and new business models. Clients frequently turn to Neel shortly before trial to take over hard-to-win cases. Neel has substantial expertise handling disputes related to patents, trade secrets, copyrights, internet law, and complex commercial technology issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNeel has led matters for some of Silicon Valley\u0026rsquo;s most legendary companies in their most significant technology disputes including groundbreaking cases for Facebook, Oracle, eBay, NVIDIA, LinkedIn, Logitech, and others. Notably, Neel defended Mark Zuckerberg and Facebook in the famed Winklevoss case that later served as the inspiration for the Academy Award winning film \u0026ldquo;The Social Network.\u0026rdquo; He helped develop and then later defended eBay with respect to its online transaction business model, creating important fundamental law that validated internet business models related to user generated content. He has prosecuted, defended and tried cases involving global patent litigation for NVIDIA as part of the smartphone patent wars. He also represented Anthony Levandowski, the star engineer at the center of the complex intellectual property dispute between Google and Uber related to self-driving car technology.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel previously clerked for the Honorable Patricia V. Trumbell in the U.S. District Court for the Northern District of California and the Honorable Chief Justice Mary Mullarkey in the Colorado Supreme Court.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel has been recognized as a top IP litigator and trailblazer by Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal, LawDragon and the IAM Global Leaders Guide. Chambers USA has described him as being \u0026ldquo;singled out for his abilities acting for hi-tech companies in patent infringement claims,\u0026rdquo; with \u0026ldquo;the ability to think outside the box\u0026rdquo; as well as having \u0026ldquo;in depth knowledge of patent law.\u0026rdquo; In addition, Chambers USA refers to him as being \u0026ldquo;knowledgeable, quick to learn, and truly innovative,\u0026rdquo; with providing \u0026ldquo;practical, business-minded patent advice\u0026rdquo; and a sensitivity \u0026ldquo;to the business objectives of patent litigation.\" Chambers Global recently recognized Neel as being \u0026ldquo;sought-after\u0026rdquo; and \u0026ldquo;valued for his strategic approach to contentious matters and his strong courtroom advocacy.\u0026rdquo; Chambers Global further stated that his peers say, \u0026ldquo;He is an outstanding lawyer who is beloved by his clients. He always puts in extra effort and really knows the law.\u0026rdquo; Most recently, IAM 1000 highlighted Neel as someone who \u0026ldquo;gives terrific legal advice and has seen a lot of success in court,\u0026rdquo; also remarking that \u0026ldquo;he exudes friendliness and confidence, and has the right personality to remain at the top.\u0026rdquo; Neel has also been recognized by U.S. News \u0026mdash; Best Lawyers in the field of patent and intellectual property litigation. In 2019, \u0026ldquo;Best Lawyers\u0026rdquo; named Neel the Trade Secret Lawyer of the Year. He was also named to the 2020 Lawyers of Color Power List and recognized by the Minority Corporate Counsel Association as a 2019 MCCA Rainmaker. Neel has also been repeatedly recognized as one of California\u0026rsquo;s Top 100 lawyers by the Daily Journal, as one of the top 500 Cyberlawyers by Law Dragon, and has been repeatedly recognized as a leading lawyer in commercial litigation.\u0026nbsp; Neel has also been recognized for lifetime achievement by Narika, a Bay Area-based organization that promotes women's independence, economic empowerment, and well-being by helping domestic violence survivors with advocacy, support, and education.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel serves or has served on numerous highly influential boards including serving as the President of the Board of Advisors of Vanderbilt University School of Law. For 23 years, he served on the Board of Directors of the Law Foundation of Silicon Valley. He currently serves on the boards of the Asian Pacific Fund, the Humane Society of Silicon Valley, the South Asian American Justice Collective, and AccessLex. He has also served on the National Advisory Committee of the National South Asian Bar Association. In addition to his board-level work, Neel has served on the Magistrate Selection Committee, the Patent Local Rules Committee, and the Federal Practice Program for the Northern District of California. He is also active in the Sedona Conference Patent Litigation section. As a passionate proponent of diversity, Neel also founded the Bay Area Diversity Career Fair.\u0026nbsp;Neel is a regularly invited speaker on the issues of intellectual property, internet law, litigating high-profile cases, diversity and inclusion, and mentorship.\u0026nbsp; The South Asian Bar Association of Northern California and the North American South Asian Bar Association have each recognized Neel for his strong leadership and mentorship of young lawyers.\u003c/p\u003e","slug":"neel-chatterjee","email":"nchatterjee@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":13,"guid":"13.capabilities","index":0,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":1,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":2,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":6,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":7,"source":"capabilities"},{"id":25,"guid":"25.capabilities","index":8,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":9,"source":"smartTags"},{"id":1,"guid":"1.capabilities","index":10,"source":"capabilities"}],"is_active":true,"last_name":"Chatterjee","nick_name":"","clerkships":[],"first_name":"Neel","title_rank":9999,"updated_by":202,"law_schools":[{"id":2442,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1994-01-01 00:00:00"},"order":0,"pin_order":null,"pin_expiration":null}],"middle_name":"","name_suffix":"","recognitions":[{"title":"Leading Litigators in America ","detail":"Lawdragon 500 (2025)"},{"title":"Litigation - Intellectual Property, Litigation - Patent and Trade Secrets Law","detail":"Best Lawyers (2022-2023)"},{"title":"Intellectual Property: Patent Litigation – California and Intellectual Property: Trademark, Copyright, and Trade Secrets","detail":"Chambers USA (2022-2025)"},{"title":"Intellectual Property – Nationwide ","detail":"Chambers USA (2025)"},{"title":"United States Hall of Fame for Trade Secrets (Litigation and Non-Contentious Matters)","detail":"Legal 500 US (2021-2024) "},{"title":"Intellectual Property: Patent","detail":"Global 2021 and 2022 "},{"title":"2021-2023 Litigation Star in California for his work in Intellectual Property ","detail":"Benchmark Litigation"},{"title":"Top IP litigator and trailblazer ","detail":"Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal and the IAM Global Leaders Guide"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eNeel Chatterjee is an internationally recognized technology litigator and trial lawyer. He has a proven track record handling hard-to-win technology cases for some of the world\u0026rsquo;s leading companies and newest disruptive technology companies. His cases often break new ground in undefined areas of the law or are existential disputes for product lines and new business models. Clients frequently turn to Neel shortly before trial to take over hard-to-win cases. Neel has substantial expertise handling disputes related to patents, trade secrets, copyrights, internet law, and complex commercial technology issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNeel has led matters for some of Silicon Valley\u0026rsquo;s most legendary companies in their most significant technology disputes including groundbreaking cases for Facebook, Oracle, eBay, NVIDIA, LinkedIn, Logitech, and others. Notably, Neel defended Mark Zuckerberg and Facebook in the famed Winklevoss case that later served as the inspiration for the Academy Award winning film \u0026ldquo;The Social Network.\u0026rdquo; He helped develop and then later defended eBay with respect to its online transaction business model, creating important fundamental law that validated internet business models related to user generated content. He has prosecuted, defended and tried cases involving global patent litigation for NVIDIA as part of the smartphone patent wars. He also represented Anthony Levandowski, the star engineer at the center of the complex intellectual property dispute between Google and Uber related to self-driving car technology.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel previously clerked for the Honorable Patricia V. Trumbell in the U.S. District Court for the Northern District of California and the Honorable Chief Justice Mary Mullarkey in the Colorado Supreme Court.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel has been recognized as a top IP litigator and trailblazer by Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal, LawDragon and the IAM Global Leaders Guide. Chambers USA has described him as being \u0026ldquo;singled out for his abilities acting for hi-tech companies in patent infringement claims,\u0026rdquo; with \u0026ldquo;the ability to think outside the box\u0026rdquo; as well as having \u0026ldquo;in depth knowledge of patent law.\u0026rdquo; In addition, Chambers USA refers to him as being \u0026ldquo;knowledgeable, quick to learn, and truly innovative,\u0026rdquo; with providing \u0026ldquo;practical, business-minded patent advice\u0026rdquo; and a sensitivity \u0026ldquo;to the business objectives of patent litigation.\" Chambers Global recently recognized Neel as being \u0026ldquo;sought-after\u0026rdquo; and \u0026ldquo;valued for his strategic approach to contentious matters and his strong courtroom advocacy.\u0026rdquo; Chambers Global further stated that his peers say, \u0026ldquo;He is an outstanding lawyer who is beloved by his clients. He always puts in extra effort and really knows the law.\u0026rdquo; Most recently, IAM 1000 highlighted Neel as someone who \u0026ldquo;gives terrific legal advice and has seen a lot of success in court,\u0026rdquo; also remarking that \u0026ldquo;he exudes friendliness and confidence, and has the right personality to remain at the top.\u0026rdquo; Neel has also been recognized by U.S. News \u0026mdash; Best Lawyers in the field of patent and intellectual property litigation. In 2019, \u0026ldquo;Best Lawyers\u0026rdquo; named Neel the Trade Secret Lawyer of the Year. He was also named to the 2020 Lawyers of Color Power List and recognized by the Minority Corporate Counsel Association as a 2019 MCCA Rainmaker. Neel has also been repeatedly recognized as one of California\u0026rsquo;s Top 100 lawyers by the Daily Journal, as one of the top 500 Cyberlawyers by Law Dragon, and has been repeatedly recognized as a leading lawyer in commercial litigation.\u0026nbsp; Neel has also been recognized for lifetime achievement by Narika, a Bay Area-based organization that promotes women's independence, economic empowerment, and well-being by helping domestic violence survivors with advocacy, support, and education.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eNeel serves or has served on numerous highly influential boards including serving as the President of the Board of Advisors of Vanderbilt University School of Law. For 23 years, he served on the Board of Directors of the Law Foundation of Silicon Valley. He currently serves on the boards of the Asian Pacific Fund, the Humane Society of Silicon Valley, the South Asian American Justice Collective, and AccessLex. He has also served on the National Advisory Committee of the National South Asian Bar Association. In addition to his board-level work, Neel has served on the Magistrate Selection Committee, the Patent Local Rules Committee, and the Federal Practice Program for the Northern District of California. He is also active in the Sedona Conference Patent Litigation section. As a passionate proponent of diversity, Neel also founded the Bay Area Diversity Career Fair.\u0026nbsp;Neel is a regularly invited speaker on the issues of intellectual property, internet law, litigating high-profile cases, diversity and inclusion, and mentorship.\u0026nbsp; The South Asian Bar Association of Northern California and the North American South Asian Bar Association have each recognized Neel for his strong leadership and mentorship of young lawyers.\u003c/p\u003e","recognitions":[{"title":"Leading Litigators in America ","detail":"Lawdragon 500 (2025)"},{"title":"Litigation - Intellectual Property, Litigation - Patent and Trade Secrets Law","detail":"Best Lawyers (2022-2023)"},{"title":"Intellectual Property: Patent Litigation – California and Intellectual Property: Trademark, Copyright, and Trade Secrets","detail":"Chambers USA (2022-2025)"},{"title":"Intellectual Property – Nationwide ","detail":"Chambers USA (2025)"},{"title":"United States Hall of Fame for Trade Secrets (Litigation and Non-Contentious Matters)","detail":"Legal 500 US (2021-2024) "},{"title":"Intellectual Property: Patent","detail":"Global 2021 and 2022 "},{"title":"2021-2023 Litigation Star in California for his work in Intellectual Property ","detail":"Benchmark Litigation"},{"title":"Top IP litigator and trailblazer ","detail":"Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal and the IAM Global Leaders Guide"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12909}]},"capability_group_id":3},"created_at":"2025-12-05T05:02:39.000Z","updated_at":"2025-12-05T05:02:39.000Z","searchable_text":"Chatterjee{{ FIELD }}{:title=\u0026gt;\"Leading Litigators in America \", :detail=\u0026gt;\"Lawdragon 500 (2025)\"}{{ FIELD }}{:title=\u0026gt;\"Litigation - Intellectual Property, Litigation - Patent and Trade Secrets Law\", :detail=\u0026gt;\"Best Lawyers (2022-2023)\"}{{ FIELD }}{:title=\u0026gt;\"Intellectual Property: Patent Litigation – California and Intellectual Property: Trademark, Copyright, and Trade Secrets\", :detail=\u0026gt;\"Chambers USA (2022-2025)\"}{{ FIELD }}{:title=\u0026gt;\"Intellectual Property – Nationwide \", :detail=\u0026gt;\"Chambers USA (2025)\"}{{ FIELD }}{:title=\u0026gt;\"United States Hall of Fame for Trade Secrets (Litigation and Non-Contentious Matters)\", :detail=\u0026gt;\"Legal 500 US (2021-2024) \"}{{ FIELD }}{:title=\u0026gt;\"Intellectual Property: Patent\", :detail=\u0026gt;\"Global 2021 and 2022 \"}{{ FIELD }}{:title=\u0026gt;\"2021-2023 Litigation Star in California for his work in Intellectual Property \", :detail=\u0026gt;\"Benchmark Litigation\"}{{ FIELD }}{:title=\u0026gt;\"Top IP litigator and trailblazer \", :detail=\u0026gt;\"Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal and the IAM Global Leaders Guide\"}{{ FIELD }}Neel Chatterjee is an internationally recognized technology litigator and trial lawyer. He has a proven track record handling hard-to-win technology cases for some of the world’s leading companies and newest disruptive technology companies. His cases often break new ground in undefined areas of the law or are existential disputes for product lines and new business models. Clients frequently turn to Neel shortly before trial to take over hard-to-win cases. Neel has substantial expertise handling disputes related to patents, trade secrets, copyrights, internet law, and complex commercial technology issues. \nNeel has led matters for some of Silicon Valley’s most legendary companies in their most significant technology disputes including groundbreaking cases for Facebook, Oracle, eBay, NVIDIA, LinkedIn, Logitech, and others. Notably, Neel defended Mark Zuckerberg and Facebook in the famed Winklevoss case that later served as the inspiration for the Academy Award winning film “The Social Network.” He helped develop and then later defended eBay with respect to its online transaction business model, creating important fundamental law that validated internet business models related to user generated content. He has prosecuted, defended and tried cases involving global patent litigation for NVIDIA as part of the smartphone patent wars. He also represented Anthony Levandowski, the star engineer at the center of the complex intellectual property dispute between Google and Uber related to self-driving car technology. \nNeel previously clerked for the Honorable Patricia V. Trumbell in the U.S. District Court for the Northern District of California and the Honorable Chief Justice Mary Mullarkey in the Colorado Supreme Court. \nNeel has been recognized as a top IP litigator and trailblazer by Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal, LawDragon and the IAM Global Leaders Guide. Chambers USA has described him as being “singled out for his abilities acting for hi-tech companies in patent infringement claims,” with “the ability to think outside the box” as well as having “in depth knowledge of patent law.” In addition, Chambers USA refers to him as being “knowledgeable, quick to learn, and truly innovative,” with providing “practical, business-minded patent advice” and a sensitivity “to the business objectives of patent litigation.\" Chambers Global recently recognized Neel as being “sought-after” and “valued for his strategic approach to contentious matters and his strong courtroom advocacy.” Chambers Global further stated that his peers say, “He is an outstanding lawyer who is beloved by his clients. He always puts in extra effort and really knows the law.” Most recently, IAM 1000 highlighted Neel as someone who “gives terrific legal advice and has seen a lot of success in court,” also remarking that “he exudes friendliness and confidence, and has the right personality to remain at the top.” Neel has also been recognized by U.S. News — Best Lawyers in the field of patent and intellectual property litigation. In 2019, “Best Lawyers” named Neel the Trade Secret Lawyer of the Year. He was also named to the 2020 Lawyers of Color Power List and recognized by the Minority Corporate Counsel Association as a 2019 MCCA Rainmaker. Neel has also been repeatedly recognized as one of California’s Top 100 lawyers by the Daily Journal, as one of the top 500 Cyberlawyers by Law Dragon, and has been repeatedly recognized as a leading lawyer in commercial litigation.  Neel has also been recognized for lifetime achievement by Narika, a Bay Area-based organization that promotes women's independence, economic empowerment, and well-being by helping domestic violence survivors with advocacy, support, and education. \nNeel serves or has served on numerous highly influential boards including serving as the President of the Board of Advisors of Vanderbilt University School of Law. For 23 years, he served on the Board of Directors of the Law Foundation of Silicon Valley. He currently serves on the boards of the Asian Pacific Fund, the Humane Society of Silicon Valley, the South Asian American Justice Collective, and AccessLex. He has also served on the National Advisory Committee of the National South Asian Bar Association. In addition to his board-level work, Neel has served on the Magistrate Selection Committee, the Patent Local Rules Committee, and the Federal Practice Program for the Northern District of California. He is also active in the Sedona Conference Patent Litigation section. As a passionate proponent of diversity, Neel also founded the Bay Area Diversity Career Fair. Neel is a regularly invited speaker on the issues of intellectual property, internet law, litigating high-profile cases, diversity and inclusion, and mentorship.  The South Asian Bar Association of Northern California and the North American South Asian Bar Association have each recognized Neel for his strong leadership and mentorship of young lawyers. Partner Leading Litigators in America  Lawdragon 500 (2025) Litigation - Intellectual Property, Litigation - Patent and Trade Secrets Law Best Lawyers (2022-2023) Intellectual Property: Patent Litigation – California and Intellectual Property: Trademark, Copyright, and Trade Secrets Chambers USA (2022-2025) Intellectual Property – Nationwide  Chambers USA (2025) United States Hall of Fame for Trade Secrets (Litigation and Non-Contentious Matters) Legal 500 US (2021-2024)  Intellectual Property: Patent Global 2021 and 2022  2021-2023 Litigation Star in California for his work in Intellectual Property  Benchmark Litigation Top IP litigator and trailblazer  Intellectual Asset Management, Managing IP, Chambers, Benchmark Litigation, National Law Journal, the Daily Journal and the IAM Global Leaders Guide Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the First Circuit U.S. Court of Appeals for the Ninth Circuit California California Bar Association Board of Directors of the Law Foundation of Silicon Valley, Board Member Asia Pacific Fund, Board Member National Advisory Committee of the National South Asian Bar Association, Board Member Served on the Magistrate Selection Committee, the Patent Local Rules Committee, and the Federal Practice Program for the Northern District of California Bay Area Diversity Career Fair, Founder","searchable_name":"Neel Chatterjee","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":443936,"version":1,"owner_type":"Person","owner_id":6649,"payload":{"bio":"\u003cp\u003eGregory S. (Greg) Chernack has more than 20 years of practice focused on trial and appellate litigation involving complex legal issues with extensive experience handling pharmaceutical and mass tort litigation in state and federal courts throughout the country, including in California, Missouri, New Jersey, and New York. This work has resulted in numerous victories before, at, and following trial. He has also worked on a number of international matters in Ecuador and Mexico. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg\u0026rsquo;s work has concentrated on developing successful defenses to lawsuits around the country by, among other things, working with expert and company witnesses in preparation for trial and engaging in complex motions practice. This work has included the representation of pharmaceutical and vaccine manufacturers in defending products liability lawsuits.\u003c/p\u003e\n\u003cp\u003eNotably, Greg represented Novartis Pharmaceuticals Corporation at numerous trials, including successfully arguing a motion for a directed verdict at the close of one, and has won a case on its behalf before the Sixth Circuit. Greg also represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. That case ultimately went to trial in federal court in the District of Columbia with six test plaintiffs and resulted in a complete defense verdict.\u003c/p\u003e\n\u003cp\u003eIn addition to his work involving product liability cases, Greg has experience before the U.S. Supreme Court involving issues ranging from patent law to immigration regulations and other complex civil litigation matters. Greg also represented pro bono the first person to be released from prison pursuant to D.C.\u0026rsquo;s Incarceration Reduction Amendment Act.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg previously served as a law clerk to the Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit, and to the Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York. He was an Articles Editor of the \u003cem\u003eYale Law Journal\u003c/em\u003e and has been repeatedly invited to serve as a judge for the semifinals of the George Washington University Law School\u0026rsquo;s Van Vleck Moot Court Competition. Greg received his JD from Yale Law School.\u003c/p\u003e","slug":"gregory-chernack","email":"gchernack@kslaw.com","phone":null,"matters":["\u003cp\u003eObtained summary judgment on behalf of Monsanto in a case alleging that Roundup exposure caused the development of skin cancer in federal court in Louisiana.\u0026nbsp; After initially obtaining summary judgment on most of plaintiffs\u0026rsquo; claims based upon the statute of limitations, his deposition of plaintiffs\u0026rsquo; causation expert resulted in the exclusion of that expert and the entry of summary judgment on the entirety of the case.\u003c/p\u003e","\u003cp\u003eSuccessfully represented Novartis Pharmaceuticals Corporation in a Tegretol Innovator Liability case in the Fifth Circuit, affirming Novartis\u0026rsquo; summary judgment victory in \u003cem\u003eJohnson v. Novartis Pharm.\u003c/em\u003e \u003cem\u003eCorp.\u003c/em\u003e in the Western District of Texas.\u003c/p\u003e","\u003cp\u003eObtained favorable outcomes for Novartis Pharmaceuticals Corporation in numerous product liability trials regarding the medications Aredia and Zometa in multiple states, including North Carolina, New Jersey, Kentucky, and Missouri.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained a directed verdict at the end of a three week trial involving Zometa in the Eastern District of California representing Novartis Pharmaceuticals Corporation in \u003cem\u003eHill v. Novartis Pharm Corp.\u003c/em\u003e before the Honorable Jed Rakoff (visiting from S.D.N.Y.).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. As many of the plaintiffs and witnesses were unable to travel to the US, he obtained their testimony in Ecuador. The case went to trial with six test plaintiffs and resulted in a complete defense verdict.\u003c/p\u003e","\u003cp\u003eRepresented pro bono the first person to be released from prison pursuant to D.C.\u0026rsquo;s Incarceration Reduction Amendment Act.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":16,"guid":"16.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":74,"guid":"74.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Chernack","nick_name":"Greg","clerkships":[{"name":"Law Clerk, Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit","years_held":"1998 - 1999"},{"name":"Law Clerk, Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York","years_held":"1999 - 2000"}],"first_name":"Gregory","title_rank":9999,"updated_by":35,"law_schools":[{"id":2605,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1998-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":"Scott","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/greg-chernack-3691b21/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eGregory S. (Greg) Chernack has more than 20 years of practice focused on trial and appellate litigation involving complex legal issues with extensive experience handling pharmaceutical and mass tort litigation in state and federal courts throughout the country, including in California, Missouri, New Jersey, and New York. This work has resulted in numerous victories before, at, and following trial. He has also worked on a number of international matters in Ecuador and Mexico. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGreg\u0026rsquo;s work has concentrated on developing successful defenses to lawsuits around the country by, among other things, working with expert and company witnesses in preparation for trial and engaging in complex motions practice. This work has included the representation of pharmaceutical and vaccine manufacturers in defending products liability lawsuits.\u003c/p\u003e\n\u003cp\u003eNotably, Greg represented Novartis Pharmaceuticals Corporation at numerous trials, including successfully arguing a motion for a directed verdict at the close of one, and has won a case on its behalf before the Sixth Circuit. Greg also represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. That case ultimately went to trial in federal court in the District of Columbia with six test plaintiffs and resulted in a complete defense verdict.\u003c/p\u003e\n\u003cp\u003eIn addition to his work involving product liability cases, Greg has experience before the U.S. Supreme Court involving issues ranging from patent law to immigration regulations and other complex civil litigation matters. Greg also represented pro bono the first person to be released from prison pursuant to D.C.\u0026rsquo;s Incarceration Reduction Amendment Act.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGreg previously served as a law clerk to the Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit, and to the Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York. He was an Articles Editor of the \u003cem\u003eYale Law Journal\u003c/em\u003e and has been repeatedly invited to serve as a judge for the semifinals of the George Washington University Law School\u0026rsquo;s Van Vleck Moot Court Competition. Greg received his JD from Yale Law School.\u003c/p\u003e","matters":["\u003cp\u003eObtained summary judgment on behalf of Monsanto in a case alleging that Roundup exposure caused the development of skin cancer in federal court in Louisiana.\u0026nbsp; After initially obtaining summary judgment on most of plaintiffs\u0026rsquo; claims based upon the statute of limitations, his deposition of plaintiffs\u0026rsquo; causation expert resulted in the exclusion of that expert and the entry of summary judgment on the entirety of the case.\u003c/p\u003e","\u003cp\u003eSuccessfully represented Novartis Pharmaceuticals Corporation in a Tegretol Innovator Liability case in the Fifth Circuit, affirming Novartis\u0026rsquo; summary judgment victory in \u003cem\u003eJohnson v. Novartis Pharm.\u003c/em\u003e \u003cem\u003eCorp.\u003c/em\u003e in the Western District of Texas.\u003c/p\u003e","\u003cp\u003eObtained favorable outcomes for Novartis Pharmaceuticals Corporation in numerous product liability trials regarding the medications Aredia and Zometa in multiple states, including North Carolina, New Jersey, Kentucky, and Missouri.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained a directed verdict at the end of a three week trial involving Zometa in the Eastern District of California representing Novartis Pharmaceuticals Corporation in \u003cem\u003eHill v. Novartis Pharm Corp.\u003c/em\u003e before the Honorable Jed Rakoff (visiting from S.D.N.Y.).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. As many of the plaintiffs and witnesses were unable to travel to the US, he obtained their testimony in Ecuador. The case went to trial with six test plaintiffs and resulted in a complete defense verdict.\u003c/p\u003e","\u003cp\u003eRepresented pro bono the first person to be released from prison pursuant to D.C.\u0026rsquo;s Incarceration Reduction Amendment Act.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11491}]},"capability_group_id":3},"created_at":"2025-12-05T05:01:36.000Z","updated_at":"2025-12-05T05:01:36.000Z","searchable_text":"Chernack{{ FIELD }}Obtained summary judgment on behalf of Monsanto in a case alleging that Roundup exposure caused the development of skin cancer in federal court in Louisiana.  After initially obtaining summary judgment on most of plaintiffs’ claims based upon the statute of limitations, his deposition of plaintiffs’ causation expert resulted in the exclusion of that expert and the entry of summary judgment on the entirety of the case.{{ FIELD }}Successfully represented Novartis Pharmaceuticals Corporation in a Tegretol Innovator Liability case in the Fifth Circuit, affirming Novartis’ summary judgment victory in Johnson v. Novartis Pharm. Corp. in the Western District of Texas.{{ FIELD }}Obtained favorable outcomes for Novartis Pharmaceuticals Corporation in numerous product liability trials regarding the medications Aredia and Zometa in multiple states, including North Carolina, New Jersey, Kentucky, and Missouri. {{ FIELD }}Obtained a directed verdict at the end of a three week trial involving Zometa in the Eastern District of California representing Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm Corp. before the Honorable Jed Rakoff (visiting from S.D.N.Y.). {{ FIELD }}Represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. As many of the plaintiffs and witnesses were unable to travel to the US, he obtained their testimony in Ecuador. The case went to trial with six test plaintiffs and resulted in a complete defense verdict.{{ FIELD }}Represented pro bono the first person to be released from prison pursuant to D.C.’s Incarceration Reduction Amendment Act.{{ FIELD }}Gregory S. (Greg) Chernack has more than 20 years of practice focused on trial and appellate litigation involving complex legal issues with extensive experience handling pharmaceutical and mass tort litigation in state and federal courts throughout the country, including in California, Missouri, New Jersey, and New York. This work has resulted in numerous victories before, at, and following trial. He has also worked on a number of international matters in Ecuador and Mexico. \nGreg’s work has concentrated on developing successful defenses to lawsuits around the country by, among other things, working with expert and company witnesses in preparation for trial and engaging in complex motions practice. This work has included the representation of pharmaceutical and vaccine manufacturers in defending products liability lawsuits.\nNotably, Greg represented Novartis Pharmaceuticals Corporation at numerous trials, including successfully arguing a motion for a directed verdict at the close of one, and has won a case on its behalf before the Sixth Circuit. Greg also represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. That case ultimately went to trial in federal court in the District of Columbia with six test plaintiffs and resulted in a complete defense verdict.\nIn addition to his work involving product liability cases, Greg has experience before the U.S. Supreme Court involving issues ranging from patent law to immigration regulations and other complex civil litigation matters. Greg also represented pro bono the first person to be released from prison pursuant to D.C.’s Incarceration Reduction Amendment Act. \nGreg previously served as a law clerk to the Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit, and to the Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York. He was an Articles Editor of the Yale Law Journal and has been repeatedly invited to serve as a judge for the semifinals of the George Washington University Law School’s Van Vleck Moot Court Competition. Greg received his JD from Yale Law School. Partner Harvard University Harvard Law School Oxford University, UK  Yale University Yale Law School Oxford University, UK  Supreme Court of the United States U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the District of New Jersey U.S. District Court for the Eastern District of Michigan Arkansas District of Columbia New Jersey New York Chair, Town Council of Section 5 of the Village of Chevy Chase, Maryland Professorial Lecturer in Law, George Washington University Law School Former Chair, D.C. Public Library Foundation Law Clerk, Honorable Ralph K. Winter, Chief Judge, U.S. Court of Appeals for the Second Circuit Law Clerk, Honorable Jack B. Weinstein, Senior Judge, U.S. District Court for the Eastern District of New York Obtained summary judgment on behalf of Monsanto in a case alleging that Roundup exposure caused the development of skin cancer in federal court in Louisiana.  After initially obtaining summary judgment on most of plaintiffs’ claims based upon the statute of limitations, his deposition of plaintiffs’ causation expert resulted in the exclusion of that expert and the entry of summary judgment on the entirety of the case. Successfully represented Novartis Pharmaceuticals Corporation in a Tegretol Innovator Liability case in the Fifth Circuit, affirming Novartis’ summary judgment victory in Johnson v. Novartis Pharm. Corp. in the Western District of Texas. Obtained favorable outcomes for Novartis Pharmaceuticals Corporation in numerous product liability trials regarding the medications Aredia and Zometa in multiple states, including North Carolina, New Jersey, Kentucky, and Missouri.  Obtained a directed verdict at the end of a three week trial involving Zometa in the Eastern District of California representing Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm Corp. before the Honorable Jed Rakoff (visiting from S.D.N.Y.).  Represented DynCorp International in a lawsuit brought against it by more than a thousand Ecuadoreans alleging personal injuries and property damage in connection with a counternarcotics aerial herbicide spraying operations in Colombia. As many of the plaintiffs and witnesses were unable to travel to the US, he obtained their testimony in Ecuador. The case went to trial with six test plaintiffs and resulted in a complete defense verdict. Represented pro bono the first person to be released from prison pursuant to D.C.’s Incarceration Reduction Amendment Act.","searchable_name":"Gregory Scott Chernack (Greg)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442382,"version":1,"owner_type":"Person","owner_id":988,"payload":{"bio":"\u003cp\u003eMike Ciatti specializes in civil litigation and investigations involving a broad range of administrative, constitutional, statutory and common law issues. As a partner in our Contracts and Business Torts practice, Mike represents clients in a variety of industries, including financial services, automotive, pharmaceuticals and healthcare. Mike is also the Deputy Office Managing Partner for our Washington, D.C., office.\u003c/p\u003e","slug":"michael-ciatti","email":"mciatti@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 financial institution\u003c/strong\u003e in parallel investigations by the Department of Justice and other agencies, such as the SEC, IRS, OCC and various State Attorneys General, as well as parallel class action litigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea multinational pharmaceutical company\u003c/strong\u003e in an indemnification claim related to breached representations and warranties in a stock purchase agreement.\u003c/p\u003e","\u003cp\u003eRepresenting \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in litigation in various federal courts over the Third Amendment to Freddie Mac\u0026rsquo;s Stock Purchase Agreement with the Department of Treasury.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in more than 40 state-wide class actions in federal courts around the country regarding the constitutionality and scope of its Congressionally mandated tax exemption.\u003c/p\u003e","\u003cp\u003eObtained summary judgment for \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in suit by mortgage brokers in United States District Court for the Central District of California that included antitrust and defamation claims. Obtained dismissal of suit by mortgage brokers against Freddie Mac in United States District Court for the Northern District of Alabama that included defamation, intentional interference with contract and conspiracy claims.\u003c/p\u003e","\u003cp\u003eDefeated motion for preliminary injunction and obtained dismissal of complaint in suit brought against \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in the United States District Court for the District of Minnesota alleging violations of the 5th Amendment of the United States Constitution related to the Home Affordable Modification Program.\u003c/p\u003e","\u003cp\u003eConducted data privacy internal investigation for \u003cstrong data-redactor-tag=\"strong\"\u003eenergy company.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003ea professional service firm\u003c/strong\u003e in lawsuits brought in various federal and state courts alleging, among other things, fraud, malpractice and RICO violations.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003eMylan Laboratories\u003c/strong\u003e in a four-week jury trial in the United States District Court for the District of Columbia involving antitrust claims arising from exclusive supply agreements with API producers.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eThe Coca-Cola Company\u003c/strong\u003e with respect to government investigations related to whistleblower allegations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea legal permanent resident\u003c/strong\u003e before the United States Supreme Court and lower courts in his successful appeal regarding the scope of a federal criminal statute that defines \u0026ldquo;crimes of violence\u0026rdquo; and provides a basis for removal from the U.S.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major textile company\u003c/strong\u003e against its insurer in a $1.1 billion property loss and business interruption claim resulting from an industrial catastrophe.\u003c/p\u003e","\u003cp\u003eObtained dismissal of claims against \u003cstrong data-redactor-tag=\"strong\"\u003eindividual defendants\u003c/strong\u003e in a lawsuit brought in the United States District Court for the Northern District of New York alleging breach of contract, fraud and RICO violations, arising out of partnership disputes related to shopping mall management.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":56}]},"expertise":[{"id":107,"guid":"107.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":4,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":5,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":8,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":11,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":12,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":13,"source":"capabilities"}],"is_active":true,"last_name":"Ciatti","nick_name":"Mike","clerkships":[],"first_name":"Michael","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMike Ciatti specializes in civil litigation and investigations involving a broad range of administrative, constitutional, statutory and common law issues. As a partner in our Contracts and Business Torts practice, Mike represents clients in a variety of industries, including financial services, automotive, pharmaceuticals and healthcare. Mike is also the Deputy Office Managing Partner for our Washington, D.C., office.\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 financial institution\u003c/strong\u003e in parallel investigations by the Department of Justice and other agencies, such as the SEC, IRS, OCC and various State Attorneys General, as well as parallel class action litigation.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea multinational pharmaceutical company\u003c/strong\u003e in an indemnification claim related to breached representations and warranties in a stock purchase agreement.\u003c/p\u003e","\u003cp\u003eRepresenting \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in litigation in various federal courts over the Third Amendment to Freddie Mac\u0026rsquo;s Stock Purchase Agreement with the Department of Treasury.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in more than 40 state-wide class actions in federal courts around the country regarding the constitutionality and scope of its Congressionally mandated tax exemption.\u003c/p\u003e","\u003cp\u003eObtained summary judgment for \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in suit by mortgage brokers in United States District Court for the Central District of California that included antitrust and defamation claims. Obtained dismissal of suit by mortgage brokers against Freddie Mac in United States District Court for the Northern District of Alabama that included defamation, intentional interference with contract and conspiracy claims.\u003c/p\u003e","\u003cp\u003eDefeated motion for preliminary injunction and obtained dismissal of complaint in suit brought against \u003cstrong data-redactor-tag=\"strong\"\u003eFreddie Mac\u003c/strong\u003e in the United States District Court for the District of Minnesota alleging violations of the 5th Amendment of the United States Constitution related to the Home Affordable Modification Program.\u003c/p\u003e","\u003cp\u003eConducted data privacy internal investigation for \u003cstrong data-redactor-tag=\"strong\"\u003eenergy company.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003ea professional service firm\u003c/strong\u003e in lawsuits brought in various federal and state courts alleging, among other things, fraud, malpractice and RICO violations.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003eMylan Laboratories\u003c/strong\u003e in a four-week jury trial in the United States District Court for the District of Columbia involving antitrust claims arising from exclusive supply agreements with API producers.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eThe Coca-Cola Company\u003c/strong\u003e with respect to government investigations related to whistleblower allegations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea legal permanent resident\u003c/strong\u003e before the United States Supreme Court and lower courts in his successful appeal regarding the scope of a federal criminal statute that defines \u0026ldquo;crimes of violence\u0026rdquo; and provides a basis for removal from the U.S.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major textile company\u003c/strong\u003e against its insurer in a $1.1 billion property loss and business interruption claim resulting from an industrial catastrophe.\u003c/p\u003e","\u003cp\u003eObtained dismissal of claims against \u003cstrong data-redactor-tag=\"strong\"\u003eindividual defendants\u003c/strong\u003e in a lawsuit brought in the United States District Court for the Northern District of New York alleging breach of contract, fraud and RICO violations, arising out of partnership disputes related to shopping mall management.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":775}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:59.000Z","updated_at":"2025-11-05T05:03:59.000Z","searchable_text":"Ciatti{{ FIELD }}Represented a Fortune 100 financial institution in parallel investigations by the Department of Justice and other agencies, such as the SEC, IRS, OCC and various State Attorneys General, as well as parallel class action litigation.{{ FIELD }}Successfully represented a multinational pharmaceutical company in an indemnification claim related to breached representations and warranties in a stock purchase agreement.{{ FIELD }}Representing Freddie Mac in litigation in various federal courts over the Third Amendment to Freddie Mac’s Stock Purchase Agreement with the Department of Treasury.{{ FIELD }}Successfully represented Freddie Mac in more than 40 state-wide class actions in federal courts around the country regarding the constitutionality and scope of its Congressionally mandated tax exemption.{{ FIELD }}Obtained summary judgment for Freddie Mac in suit by mortgage brokers in United States District Court for the Central District of California that included antitrust and defamation claims. Obtained dismissal of suit by mortgage brokers against Freddie Mac in United States District Court for the Northern District of Alabama that included defamation, intentional interference with contract and conspiracy claims.{{ FIELD }}Defeated motion for preliminary injunction and obtained dismissal of complaint in suit brought against Freddie Mac in the United States District Court for the District of Minnesota alleging violations of the 5th Amendment of the United States Constitution related to the Home Affordable Modification Program.{{ FIELD }}Conducted data privacy internal investigation for energy company.{{ FIELD }}Defended a professional service firm in lawsuits brought in various federal and state courts alleging, among other things, fraud, malpractice and RICO violations.{{ FIELD }}Defended Mylan Laboratories in a four-week jury trial in the United States District Court for the District of Columbia involving antitrust claims arising from exclusive supply agreements with API producers.{{ FIELD }}Represented The Coca-Cola Company with respect to government investigations related to whistleblower allegations.{{ FIELD }}Represented a legal permanent resident before the United States Supreme Court and lower courts in his successful appeal regarding the scope of a federal criminal statute that defines “crimes of violence” and provides a basis for removal from the U.S.{{ FIELD }}Represented a major textile company against its insurer in a $1.1 billion property loss and business interruption claim resulting from an industrial catastrophe.{{ FIELD }}Obtained dismissal of claims against individual defendants in a lawsuit brought in the United States District Court for the Northern District of New York alleging breach of contract, fraud and RICO violations, arising out of partnership disputes related to shopping mall management.{{ FIELD }}Mike Ciatti specializes in civil litigation and investigations involving a broad range of administrative, constitutional, statutory and common law issues. As a partner in our Contracts and Business Torts practice, Mike represents clients in a variety of industries, including financial services, automotive, pharmaceuticals and healthcare. Mike is also the Deputy Office Managing Partner for our Washington, D.C., office. Michael J Ciatti Partner University of Virginia University of Virginia School of Law University of Virginia University of Virginia School of Law U.S. Court of Appeals for the Fourth Circuit U.S. District Court for the Eastern District of Virginia District of Columbia Virginia American Bar Association Virginia State Bar Represented a Fortune 100 financial institution in parallel investigations by the Department of Justice and other agencies, such as the SEC, IRS, OCC and various State Attorneys General, as well as parallel class action litigation. Successfully represented a multinational pharmaceutical company in an indemnification claim related to breached representations and warranties in a stock purchase agreement. Representing Freddie Mac in litigation in various federal courts over the Third Amendment to Freddie Mac’s Stock Purchase Agreement with the Department of Treasury. Successfully represented Freddie Mac in more than 40 state-wide class actions in federal courts around the country regarding the constitutionality and scope of its Congressionally mandated tax exemption. Obtained summary judgment for Freddie Mac in suit by mortgage brokers in United States District Court for the Central District of California that included antitrust and defamation claims. Obtained dismissal of suit by mortgage brokers against Freddie Mac in United States District Court for the Northern District of Alabama that included defamation, intentional interference with contract and conspiracy claims. Defeated motion for preliminary injunction and obtained dismissal of complaint in suit brought against Freddie Mac in the United States District Court for the District of Minnesota alleging violations of the 5th Amendment of the United States Constitution related to the Home Affordable Modification Program. Conducted data privacy internal investigation for energy company. Defended a professional service firm in lawsuits brought in various federal and state courts alleging, among other things, fraud, malpractice and RICO violations. Defended Mylan Laboratories in a four-week jury trial in the United States District Court for the District of Columbia involving antitrust claims arising from exclusive supply agreements with API producers. Represented The Coca-Cola Company with respect to government investigations related to whistleblower allegations. Represented a legal permanent resident before the United States Supreme Court and lower courts in his successful appeal regarding the scope of a federal criminal statute that defines “crimes of violence” and provides a basis for removal from the U.S. Represented a major textile company against its insurer in a $1.1 billion property loss and business interruption claim resulting from an industrial catastrophe. Obtained dismissal of claims against individual defendants in a lawsuit brought in the United States District Court for the Northern District of New York alleging breach of contract, fraud and RICO violations, arising out of partnership disputes related to shopping mall management.","searchable_name":"Michael J. Ciatti (Mike)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}